{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:30Z","timestamp":1792788150074,"version":"4.5.0"},"reference-count":334,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82303766"],"award-info":[{"award-number":["82303766"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["82525069"],"award-info":[{"award-number":["82525069"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA0919100"],"award-info":[{"award-number":["2024YFA0919100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04720-8","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:50:58Z","timestamp":1783050658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting tumor-associated bacteria in digestive system cancers: carcinogenic mechanisms and nano-regulate platform design"],"prefix":"10.1186","volume":"24","author":[{"given":"Hongyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QI","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianren","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"4720_CR1","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1126\/science.1177486","volume":"326","author":"EK Costello","year":"2009","unstructured":"Costello EK, et al. Bacterial community variation in human body habitats across space and time. Science. 2009;326:1694\u20137.","journal-title":"Science"},{"key":"4720_CR2","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature06244","volume":"449","author":"PJ Turnbaugh","year":"2007","unstructured":"Turnbaugh PJ, et al. The human microbiome project. Nature. 2007;449:804\u201310.","journal-title":"Nature"},{"key":"4720_CR3","doi-asserted-by":"publisher","first-page":"e1002533","DOI":"10.1371\/journal.pbio.1002533","volume":"14","author":"R Sender","year":"2016","unstructured":"Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016;14:e1002533.","journal-title":"PLoS Biol"},{"key":"4720_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121\u201341.","journal-title":"Cell"},{"key":"4720_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1053\/j.gastro.2020.11.041","volume":"160","author":"V Matson","year":"2021","unstructured":"Matson V, Chervin CS, Gajewski TF. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy. Gastroenterology. 2021;160:600\u201313.","journal-title":"Gastroenterology"},{"key":"4720_CR6","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s42255-025-01287-w","volume":"7","author":"A Nobels","year":"2025","unstructured":"Nobels A, van Marcke C, Jordan BF, Van Hul M, Cani PD. The gut microbiome and cancer: from tumorigenesis to therapy. Nat Metab. 2025;7:895\u2013917.","journal-title":"Nat Metab"},{"key":"4720_CR7","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/s41590-025-02281-w","volume":"26","author":"ID Iliev","year":"2025","unstructured":"Iliev ID, et al. Microbiota-mediated mechanisms of mucosal immunity across the lifespan. Nat Immunol. 2025;26:1645\u201359.","journal-title":"Nat Immunol"},{"key":"4720_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41581-022-00647-z","volume":"19","author":"H Krukowski","year":"2023","unstructured":"Krukowski H, et al. Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential. Nat Rev Nephrol. 2023;19:87\u2013101.","journal-title":"Nat Rev Nephrol"},{"key":"4720_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","volume":"18","author":"AH Tan","year":"2022","unstructured":"Tan AH, Lim SY, Lang AE. The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic. Nat Rev Neurol. 2022;18:476\u201395.","journal-title":"Nat Rev Neurol"},{"key":"4720_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"Structure","year":"2012","unstructured":"Structure. function and diversity of the healthy human microbiome. Nature. 2012;486:207\u201314.","journal-title":"Nature"},{"key":"4720_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu CL, Schnabl B. The gut-liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol. 2023;21:719\u201333.","journal-title":"Nat Rev Microbiol"},{"key":"4720_CR12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cgh.2024.05.049","volume":"23","author":"AN Ananthakrishnan","year":"2025","unstructured":"Ananthakrishnan AN, Whelan K, Allegretti JR, Sokol H. Diet and Microbiome-Directed Therapy 2.0 for IBD. Clin Gastroenterol Hepatol. 2025;23:406\u201318.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4720_CR13","doi-asserted-by":"publisher","first-page":"e2200470","DOI":"10.1002\/advs.202200470","volume":"9","author":"Y Xie","year":"2022","unstructured":"Xie Y, et al. Microbiota in Tumors: From Understanding to Application. Adv Sci (Weinh). 2022;9:e2200470.","journal-title":"Adv Sci (Weinh)"},{"key":"4720_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrmicro2819","volume":"10","author":"H Tjalsma","year":"2012","unstructured":"Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 2012;10:575\u201382.","journal-title":"Nat Rev Microbiol"},{"key":"4720_CR15","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3748\/wjg.v12.i19.3038","volume":"12","author":"HO Nilsson","year":"2006","unstructured":"Nilsson HO, Stenram U, Ihse I, Wadstrom T. Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients. World J Gastroenterol. 2006;12:3038\u201343.","journal-title":"World J Gastroenterol"},{"key":"4720_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41568-023-00594-2","volume":"23","author":"G El Tekle","year":"2023","unstructured":"El Tekle G, Garrett WS. Bacteria in cancer initiation, promotion and progression. Nat Rev Cancer. 2023;23:600\u201318.","journal-title":"Nat Rev Cancer"},{"key":"4720_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41579-024-01103-4","volume":"23","author":"T Turocy","year":"2025","unstructured":"Turocy T, Crawford JM. Bacterial small molecule metabolites implicated in gastrointestinal cancer development. Nat Rev Microbiol. 2025;23:106\u201321.","journal-title":"Nat Rev Microbiol"},{"key":"4720_CR18","doi-asserted-by":"publisher","first-page":"e12521","DOI":"10.1002\/jev2.12521","volume":"13","author":"A Liang","year":"2024","unstructured":"Liang A, Korani L, Yeung CLS, Tey SK, Yam J. W. P. The emerging role of bacterial extracellular vesicles in human cancers. J Extracell Vesicles. 2024;13:e12521.","journal-title":"J Extracell Vesicles"},{"key":"4720_CR19","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41591-022-01779-2","volume":"28","author":"EM Park","year":"2022","unstructured":"Park EM, et al. Targeting the gut and tumor microbiota in cancer. Nat Med. 2022;28:690\u2013703.","journal-title":"Nat Med"},{"key":"4720_CR20","doi-asserted-by":"crossref","unstructured":"Gazzaniga FS, Kasper DL. The gut microbiome and cancer response to immune checkpoint inhibitors. J Clin Invest. 2025;135:3.","DOI":"10.1172\/JCI184321"},{"key":"4720_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","volume":"20","author":"CC Wong","year":"2023","unstructured":"Wong CC, Yu J. Gut microbiota in colorectal cancer development and therapy. Nat Rev Clin Oncol. 2023;20:429\u201352.","journal-title":"Nat Rev Clin Oncol"},{"key":"4720_CR22","doi-asserted-by":"crossref","unstructured":"Conti G, et al. Pharmacomicrobiomics in anticancer therapies: why the gut microbiota should be pointed out. Genes (Basel). 2022;14(1):55.","DOI":"10.3390\/genes14010055"},{"key":"4720_CR23","doi-asserted-by":"publisher","first-page":"115345","DOI":"10.1016\/j.addr.2024.115345","volume":"211","author":"G Ji","year":"2024","unstructured":"Ji G, Zhao J, Si X, Song W. Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria. Adv Drug Deliv Rev. 2024;211:115345.","journal-title":"Adv Drug Deliv Rev"},{"key":"4720_CR24","doi-asserted-by":"crossref","unstructured":"Jiang SS, Chen YX, Fang JY. Fusobacterium nucleatum: ecology, pathogenesis and clinical implications. Nat Rev Microbiol. 2026;24(3):197\u2013214.","DOI":"10.1038\/s41579-025-01237-z"},{"key":"4720_CR25","doi-asserted-by":"publisher","first-page":"100909","DOI":"10.1016\/j.jhepr.2023.100909","volume":"5","author":"J Fujiki","year":"2023","unstructured":"Fujiki J, Schnabl B. Phage therapy: Targeting intestinal bacterial microbiota for the treatment of liver diseases. JHEP Rep. 2023;5:100909.","journal-title":"JHEP Rep"},{"key":"4720_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41522-025-00786-8","volume":"11","author":"W Lei","year":"2025","unstructured":"Lei W, Zhou K, Lei Y, Li Q, Zhu H. Gut microbiota shapes cancer immunotherapy responses. NPJ Biofilms Microbiomes. 2025;11:143.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"4720_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40164-023-00442-x","volume":"12","author":"M Zhang","year":"2023","unstructured":"Zhang M, Liu J, Xia Q. Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target. Exp Hematol Oncol. 2023;12:84.","journal-title":"Exp Hematol Oncol"},{"key":"4720_CR28","doi-asserted-by":"crossref","unstructured":"Ma Y, et al. Effect of nanomaterials on gut microbiota. Toxics.2023;11(4):384.","DOI":"10.3390\/toxics11040384"},{"key":"4720_CR29","doi-asserted-by":"crossref","unstructured":"Homayun B, Lin X, Choi HJ. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics. 2019;11(3):129.","DOI":"10.3390\/pharmaceutics11030129"},{"key":"4720_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1208\/s12248-016-9889-y","volume":"18","author":"CR Jones","year":"2016","unstructured":"Jones CR, et al. Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass Elimination. Aaps j. 2016;18:589\u2013604.","journal-title":"Aaps j"},{"key":"4720_CR31","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1021\/acsnano.9b08142","volume":"14","author":"YH Cheng","year":"2020","unstructured":"Cheng YH, He C, Riviere JE, Monteiro-Riviere NA, Lin Z. Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach. ACS Nano. 2020;14:3075\u201395.","journal-title":"ACS Nano"},{"key":"4720_CR32","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"CH Heldin","year":"2004","unstructured":"Heldin CH, Rubin K, Pietras K, Ostman A. High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer. 2004;4:806\u201313.","journal-title":"Nat Rev Cancer"},{"key":"4720_CR33","first-page":"802","volume":"34","author":"L Michailidis","year":"2021","unstructured":"Michailidis L, Currier AC, Le M, Flomenhoft DR. Adverse events of fecal microbiota transplantation: a meta-analysis of high-quality studies. Ann Gastroenterol. 2021;34:802\u201314.","journal-title":"Ann Gastroenterol"},{"key":"4720_CR34","doi-asserted-by":"crossref","unstructured":"Gaurav A, Bakht P, Saini M, Pandey S, Pathania R. Role of bacterial efflux pumps in antibiotic resistance, virulence, and strategies to discover novel efflux pump inhibitors. Microbiol (Reading). 2023;169(5):001333.","DOI":"10.1099\/mic.0.001333"},{"key":"4720_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s44259-024-00046-3","volume":"2","author":"HY Liu","year":"2024","unstructured":"Liu HY, Prentice EL, Webber MA. Mechanisms of antimicrobial resistance in biofilms. NPJ Antimicrob Resist. 2024;2:27.","journal-title":"NPJ Antimicrob Resist"},{"key":"4720_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20:101\u201324.","journal-title":"Nat Rev Drug Discov"},{"key":"4720_CR37","doi-asserted-by":"publisher","first-page":"1177151","DOI":"10.3389\/fbioe.2023.1177151","volume":"11","author":"X Cheng","year":"2023","unstructured":"Cheng X, Xie Q, Sun Y. Advances in nanomaterial-based targeted drug delivery systems. Front Bioeng Biotechnol. 2023;11:1177151.","journal-title":"Front Bioeng Biotechnol"},{"key":"4720_CR38","first-page":"386","volume":"5","author":"H Hu","year":"2024","unstructured":"Hu H, Busa P, Zhao Y, Zhao C. Externally triggered drug delivery systems. Smart Mater Med. 2024;5:386\u2013408.","journal-title":"Smart Mater Med"},{"key":"4720_CR39","doi-asserted-by":"crossref","unstructured":"Jin Z, Al Amili M, Guo S. Tumor Microenvironment-Responsive Drug Delivery Based on Polymeric Micelles for Precision Cancer Therapy: Strategies and Prospects. Biomedicines 12 (2024).","DOI":"10.3390\/biomedicines12020417"},{"key":"4720_CR40","doi-asserted-by":"publisher","first-page":"101601","DOI":"10.1016\/j.mtbio.2025.101601","volume":"31","author":"Q Han","year":"2025","unstructured":"Han Q, Li J, Li Z, Aishajiang R, Yu D. Novel therapeutic strategies and recent advances in gut microbiota synergy with nanotechnology for colorectal cancer treatment. Mater Today Bio. 2025;31:101601.","journal-title":"Mater Today Bio"},{"key":"4720_CR41","doi-asserted-by":"publisher","first-page":"eabn4948","DOI":"10.1126\/scisignal.abn4948","volume":"15","author":"B Udayasuryan","year":"2022","unstructured":"Udayasuryan B, et al. Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling. Sci Signal. 2022;15:eabn4948.","journal-title":"Sci Signal"},{"key":"4720_CR42","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.1038\/s44318-025-00542-w","volume":"44","author":"J Karta","year":"2025","unstructured":"Karta J, et al. Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancer. Embo j. 2025;44:5375\u201393.","journal-title":"Embo j"},{"key":"4720_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13046-020-01677-w","volume":"39","author":"P Guo","year":"2020","unstructured":"Guo P, et al. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2. J Exp Clin Cancer Res. 2020;39:202.","journal-title":"J Exp Clin Cancer Res"},{"key":"4720_CR44","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.gastro.2016.11.018","volume":"152","author":"Y Yang","year":"2017","unstructured":"Yang Y, et al. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-\u03baB, and Up-regulating Expression of MicroRNA-21. Gastroenterology. 2017;152:851\u2013e866824.","journal-title":"Gastroenterology"},{"key":"4720_CR45","doi-asserted-by":"crossref","unstructured":"Zhang S, et al. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. J Exp Clin Cancer Res. 2019;38:14","DOI":"10.1186\/s13046-018-0985-y"},{"key":"4720_CR46","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1038\/s41564-024-01784-w","volume":"9","author":"L Zhang","year":"2024","unstructured":"Zhang L, et al. The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesis. Nat Microbiol. 2024;9:2292\u2013307.","journal-title":"Nat Microbiol"},{"key":"4720_CR47","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ccell.2025.09.010","volume":"44","author":"JL Galeano Ni\u00f1o","year":"2026","unstructured":"Galeano Ni\u00f1o JL, et al. Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest. Cancer Cell. 2026;44:166\u2013e186116.","journal-title":"Cancer Cell"},{"key":"4720_CR48","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1038\/s41467-024-45572-w","volume":"15","author":"H Zhu","year":"2024","unstructured":"Zhu H, et al. Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15. Nat Commun. 2024;15:1688.","journal-title":"Nat Commun"},{"key":"4720_CR49","doi-asserted-by":"crossref","unstructured":"Ko SH, Choi JH, Kim JM. Bacteroides fragilis enterotoxin induces autophagy through an AMPK and FoxO3-pathway, leading to the inhibition of apoptosis in intestinal epithelial cells. Toxins (Basel). 2023;15(9):544.","DOI":"10.3390\/toxins15090544"},{"key":"4720_CR50","doi-asserted-by":"crossref","unstructured":"Jeon JI, Choi JH, Lee KH, Kim JM. Bacteroides fragilis enterotoxin induces sulfiredoxin-1 expression in intestinal epithelial cell lines through a mitogen-activated protein kinases- and Nrf2-dependent pathway, leading to the suppression of apoptosis. Int J Mol Sci. 2020;21(15):5383.","DOI":"10.3390\/ijms21155383"},{"key":"4720_CR51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13099-022-00489-x","volume":"14","author":"RV Purcell","year":"2022","unstructured":"Purcell RV, Permain J, Keenan JI. Enterotoxigenic Bacteroides fragilis activates IL-8 expression through Stat3 in colorectal cancer cells. Gut Pathog. 2022;14:16.","journal-title":"Gut Pathog"},{"key":"4720_CR52","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/gast.2003.50047","volume":"124","author":"S Wu","year":"2003","unstructured":"Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology. 2003;124:392\u2013400.","journal-title":"Gastroenterology"},{"key":"4720_CR53","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1242\/jcs.03455","volume":"120","author":"S Wu","year":"2007","unstructured":"Wu S, Rhee KJ, Zhang M, Franco A, Sears CL. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage. J Cell Sci. 2007;120:1944\u201352.","journal-title":"J Cell Sci"},{"key":"4720_CR54","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1038\/oncsis.2014.20","volume":"3","author":"R Lu","year":"2014","unstructured":"Lu R, et al. Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway. Oncogenesis. 2014;3:e105.","journal-title":"Oncogenesis"},{"key":"4720_CR55","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.neo.2016.04.001","volume":"18","author":"R Lu","year":"2016","unstructured":"Lu R, et al. Salmonella Protein AvrA Activates the STAT3 Signaling Pathway in Colon Cancer. Neoplasia. 2016;18:307\u201316.","journal-title":"Neoplasia"},{"key":"4720_CR56","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.febslet.2010.01.024","volume":"584","author":"X Liu","year":"2010","unstructured":"Liu X, Lu R, Wu S, Sun J. Salmonella regulation of intestinal stem cells through the Wnt\/beta-catenin pathway. FEBS Lett. 2010;584:911\u20136.","journal-title":"FEBS Lett"},{"key":"4720_CR57","doi-asserted-by":"publisher","first-page":"G1113","DOI":"10.1152\/ajpgi.00453.2011","volume":"303","author":"R Lu","year":"2012","unstructured":"Lu R, et al. Consistent activation of the \u03b2-catenin pathway by Salmonella type-three secretion effector protein AvrA in chronically infected intestine. Am J Physiol Gastrointest Liver Physiol. 2012;303:G1113\u20131125.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4720_CR58","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.chom.2015.05.002","volume":"17","author":"T Scanu","year":"2015","unstructured":"Scanu T, et al. Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma. Cell Host Microbe. 2015;17:763\u201374.","journal-title":"Cell Host Microbe"},{"key":"4720_CR59","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1128\/IAI.00302-15","volume":"83","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, et al. Noncanonical activation of \u03b2-catenin by Porphyromonas gingivalis. Infect Immun. 2015;83:3195\u2013203.","journal-title":"Infect Immun"},{"key":"4720_CR60","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.micinf.2007.10.011","volume":"10","author":"M Kuboniwa","year":"2008","unstructured":"Kuboniwa M, et al. P. gingivalis accelerates gingival epithelial cell progression through the cell cycle. Microbes Infect. 2008;10:122\u20138.","journal-title":"Microbes Infect"},{"key":"4720_CR61","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1128\/IAI.72.7.3743-3751.2004","volume":"72","author":"O Yilmaz","year":"2004","unstructured":"Yilmaz O, Jungas T, Verbeke P, Ojcius DM. Activation of the phosphatidylinositol 3-kinase\/Akt pathway contributes to survival of primary epithelial cells infected with the periodontal pathogen Porphyromonas gingivalis. Infect Immun. 2004;72:3743\u201351.","journal-title":"Infect Immun"},{"key":"4720_CR62","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.chom.2024.07.001","volume":"32","author":"P Huang","year":"2024","unstructured":"Huang P, et al. Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating ERBB2-MAPK. Cell Host Microbe. 2024;32:1365\u2013e13791310.","journal-title":"Cell Host Microbe"},{"key":"4720_CR63","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1128\/IAI.66.5.1934-1940.1998","volume":"66","author":"CA Whitehouse","year":"1998","unstructured":"Whitehouse CA, et al. Campylobacter jejuni cytolethal distending toxin causes a G2-phase cell cycle block. Infect Immun. 1998;66:1934\u201340.","journal-title":"Infect Immun"},{"key":"4720_CR64","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.immuni.2013.11.018","volume":"40","author":"X Song","year":"2014","unstructured":"Song X, et al. Alterations in the microbiota drive interleukin-17\u00a0C production from intestinal epithelial cells to promote tumorigenesis. Immunity. 2014;40:140\u201352.","journal-title":"Immunity"},{"key":"4720_CR65","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1053\/j.gastro.2017.01.009","volume":"152","author":"H Tsoi","year":"2017","unstructured":"Tsoi H, et al. Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice. Gastroenterology. 2017;152:1419\u2013e14331415.","journal-title":"Gastroenterology"},{"key":"4720_CR66","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s10620-009-0946-6","volume":"55","author":"S Takayama","year":"2010","unstructured":"Takayama S, Takahashi H, Matsuo Y, Okada Y, Takeyama H. Effect of Helicobacter bilis infection on human bile duct cancer cells. Dig Dis Sci. 2010;55:1905\u201310.","journal-title":"Dig Dis Sci"},{"key":"4720_CR67","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.chom.2024.07.012","volume":"32","author":"YM Ren","year":"2024","unstructured":"Ren YM, et al. BCAA-producing Clostridium symbiosum promotes colorectal tumorigenesis through the modulation of host cholesterol metabolism. Cell Host Microbe. 2024;32:1519\u2013e15351517.","journal-title":"Cell Host Microbe"},{"key":"4720_CR68","doi-asserted-by":"publisher","first-page":"2555446","DOI":"10.1080\/19490976.2025.2555446","volume":"17","author":"R Zhang","year":"2025","unstructured":"Zhang R, et al. A new gut pathogenic bacteria and its metabolites promote colorectal cancer development and act as non-invasive early diagnostic biomarkers. Gut Microbes. 2025;17:2555446.","journal-title":"Gut Microbes"},{"key":"4720_CR69","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu T, et al. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell. 2017;170:548\u2013e563516.","journal-title":"Cell"},{"key":"4720_CR70","doi-asserted-by":"publisher","first-page":"106770","DOI":"10.1016\/j.isci.2023.106770","volume":"26","author":"B Tang","year":"2023","unstructured":"Tang B, et al. MicroRNA-31 induced by Fusobacterium nucleatum infection promotes colorectal cancer tumorigenesis. iScience. 2023;26:106770.","journal-title":"iScience"},{"key":"4720_CR71","doi-asserted-by":"publisher","first-page":"217810","DOI":"10.1016\/j.canlet.2025.217810","volume":"627","author":"Y Sun","year":"2025","unstructured":"Sun Y, et al. Fusobacterium nucleatum enhances cholesterol biosynthesis in colorectal cancer via miR-130a-3p-mediated AMPK inhibition, a process counteracted by butyrate. Cancer Lett. 2025;627:217810.","journal-title":"Cancer Lett"},{"key":"4720_CR72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12275-023-00100-1","volume":"62","author":"W Zeng","year":"2024","unstructured":"Zeng W, Pan J, Ye G. miR-135b Aggravates Fusobacterium nucleatum-Induced Cisplatin Resistance in Colorectal Cancer by Targeting KLF13. J Microbiol. 2024;62:63\u201373.","journal-title":"J Microbiol"},{"key":"4720_CR73","doi-asserted-by":"publisher","first-page":"e0215088","DOI":"10.1371\/journal.pone.0215088","volume":"14","author":"YY Feng","year":"2019","unstructured":"Feng YY, et al. Alteration of microRNA-4474\/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum. PLoS ONE. 2019;14:e0215088.","journal-title":"PLoS ONE"},{"key":"4720_CR74","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12951-024-02331-9","volume":"22","author":"B Hui","year":"2024","unstructured":"Hui B, et al. Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085. J Nanobiotechnol. 2024;22:62.","journal-title":"J Nanobiotechnol"},{"key":"4720_CR75","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41419-019-1925-2","volume":"10","author":"Y Bao","year":"2019","unstructured":"Bao Y, et al. Long noncoding RNA BFAL1 mediates enterotoxigenic Bacteroides fragilis-related carcinogenesis in colorectal cancer via the RHEB\/mTOR pathway. Cell Death Dis. 2019;10:675.","journal-title":"Cell Death Dis"},{"key":"4720_CR76","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1136\/gutjnl-2013-305257","volume":"63","author":"A Cougnoux","year":"2014","unstructured":"Cougnoux A, et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut. 2014;63:1932\u201342.","journal-title":"Gut"},{"key":"4720_CR77","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40168-020-00847-4","volume":"8","author":"X Xia","year":"2020","unstructured":"Xia X, et al. Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer. Microbiome. 2020;8:108.","journal-title":"Microbiome"},{"key":"4720_CR78","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00428-017-2171-6","volume":"471","author":"HE Park","year":"2017","unstructured":"Park HE, Kim JH, Cho NY, Lee HS, Kang GH. Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma. Virchows Arch. 2017;471:329\u201336.","journal-title":"Virchows Arch"},{"key":"4720_CR79","doi-asserted-by":"crossref","unstructured":"Hong J, et al. F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer. Gut. 2021;70:2123\u201337.","DOI":"10.1136\/gutjnl-2020-322780"},{"key":"4720_CR80","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1111\/cas.15536","volume":"113","author":"Q Xu","year":"2022","unstructured":"Xu Q, et al. Fusobacterium nucleatum induces excess methyltransferase-like 3-mediated microRNA-4717-3p maturation to promote colorectal cancer cell proliferation. Cancer Sci. 2022;113:3787\u2013800.","journal-title":"Cancer Sci"},{"key":"4720_CR81","doi-asserted-by":"publisher","first-page":"1788900","DOI":"10.1080\/19490976.2020.1788900","volume":"12","author":"QQ Liu","year":"2020","unstructured":"Liu QQ, et al. Enterotoxigenic Bacteroides fragilis induces the stemness in colorectal cancer via upregulating histone demethylase JMJD2B. Gut Microbes. 2020;12:1788900.","journal-title":"Gut Microbes"},{"key":"4720_CR82","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41577-023-00951-0","volume":"24","author":"SJ Blake","year":"2024","unstructured":"Blake SJ, Wolf Y, Boursi B, Lynn DJ. Role of the microbiota in response to and recovery from cancer therapy. Nat Rev Immunol. 2024;24:308\u201325.","journal-title":"Nat Rev Immunol"},{"key":"4720_CR83","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1136\/gutjnl-2015-310101","volume":"65","author":"K Mima","year":"2016","unstructured":"Mima K, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016;65:1973\u201380.","journal-title":"Gut"},{"key":"4720_CR84","doi-asserted-by":"publisher","first-page":"15009","DOI":"10.1038\/nmicrobiol.2015.9","volume":"1","author":"JJ Mousa","year":"2016","unstructured":"Mousa JJ, et al. MATE transport of the E. coli-derived genotoxin colibactin. Nat Microbiol. 2016;1:15009.","journal-title":"Nat Microbiol"},{"key":"4720_CR85","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.1127059","volume":"313","author":"JP Nougayr\u00e8de","year":"2006","unstructured":"Nougayr\u00e8de JP, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313:848\u201351.","journal-title":"Science"},{"key":"4720_CR86","doi-asserted-by":"publisher","unstructured":"Bossuet-Greif N, et al. The colibactin genotoxin generates DNA interstrand cross-links in infected cells. mBio. 2018;9. https:\/\/doi.org\/10.1128\/mbio.02393-17.","DOI":"10.1128\/mbio.02393-17"},{"key":"4720_CR87","doi-asserted-by":"publisher","first-page":"2310215","DOI":"10.1080\/19490976.2024.2310215","volume":"16","author":"G Dalmasso","year":"2024","unstructured":"Dalmasso G, et al. Colibactin-producing Escherichia coli enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence. Gut Microbes. 2024;16:2310215.","journal-title":"Gut Microbes"},{"key":"4720_CR88","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/gutjnl-2018-317200","volume":"68","author":"Z He","year":"2019","unstructured":"He Z, et al. Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin. Gut. 2019;68:289\u2013300.","journal-title":"Gut"},{"key":"4720_CR89","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jcmgh.2017.02.002","volume":"3","author":"LD Butcher","year":"2017","unstructured":"Butcher LD, den Hartog G, Ernst PB, Crowe SE. Oxidative Stress Resulting From Helicobacter pylori Infection Contributes to Gastric Carcinogenesis. Cell Mol Gastroenterol Hepatol. 2017;3:316\u201322.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4720_CR90","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jcmgh.2024.01.010","volume":"17","author":"Y Miyakawa","year":"2024","unstructured":"Miyakawa Y, et al. Gut Bacteria-derived Membrane Vesicles Induce Colonic Dysplasia by Inducing DNA Damage in Colon Epithelial Cells. Cell Mol Gastroenterol Hepatol. 2024;17:745\u201367.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4720_CR91","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1099\/0022-1317-50-11-952","volume":"50","author":"M Sasaki","year":"2001","unstructured":"Sasaki M, et al. Antigenic characterisation of a novel Streptococcus anginosus antigen that induces nitric oxide synthesis by murine peritoneal exudate cells. J Med Microbiol. 2001;50:952\u20138.","journal-title":"J Med Microbiol"},{"key":"4720_CR92","doi-asserted-by":"crossref","unstructured":"Shimoyama Y, Ishikawa T, Kodama Y, Kimura S, Sasaki M. Tyrosine tRNA synthetase as a novel extracellular immunomodulatory protein in Streptococcus anginosus. FEMS Microbiol Lett. 2020;367(18):fnaa153.","DOI":"10.1093\/femsle\/fnaa153"},{"key":"4720_CR93","doi-asserted-by":"publisher","first-page":"15354","DOI":"10.1073\/pnas.1010203108","volume":"108","author":"AC Goodwin","year":"2011","unstructured":"Goodwin AC, et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci U S A. 2011;108:15354\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4720_CR94","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1089\/dna.2019.5064","volume":"39","author":"F Geng","year":"2020","unstructured":"Geng F, Zhang Y, Lu Z, Zhang S, Pan Y. Fusobacterium nucleatum Caused DNA Damage and Promoted Cell Proliferation by the Ku70\/p53 Pathway in Oral Cancer Cells. DNA Cell Biol. 2020;39:144\u201351.","journal-title":"DNA Cell Biol"},{"key":"4720_CR95","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/mc.22590","volume":"56","author":"JC Santos","year":"2017","unstructured":"Santos JC, et al. Helicobacter pylori infection modulates the expression of miRNAs associated with DNA mismatch repair pathway. Mol Carcinog. 2017;56:1372\u20139.","journal-title":"Mol Carcinog"},{"key":"4720_CR96","doi-asserted-by":"publisher","first-page":"2463581","DOI":"10.1080\/19490976.2025.2463581","volume":"17","author":"X Xu","year":"2025","unstructured":"Xu X, et al. Helicobacter pylori infection induces DNA double-strand breaks through the ACVR1\/IRF3\/POLD1 signaling axis to drive gastric tumorigenesis. Gut Microbes. 2025;17:2463581.","journal-title":"Gut Microbes"},{"key":"4720_CR97","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1053\/j.gastro.2006.11.040","volume":"132","author":"X Wang","year":"2007","unstructured":"Wang X, Huycke MM. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology. 2007;132:551\u201361.","journal-title":"Gastroenterology"},{"key":"4720_CR98","doi-asserted-by":"publisher","first-page":"9909","DOI":"10.1158\/0008-5472.CAN-08-1551","volume":"68","author":"X Wang","year":"2008","unstructured":"Wang X, et al. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res. 2008;68:9909\u201317.","journal-title":"Cancer Res"},{"key":"4720_CR99","doi-asserted-by":"publisher","first-page":"e00152","DOI":"10.1128\/mBio.00152-13","volume":"4","author":"OD Maddocks","year":"2013","unstructured":"Maddocks OD, Scanlon KM, Donnenberg MS. An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins. mBio. 2013;4:e00152\u201300113.","journal-title":"mBio"},{"key":"4720_CR100","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.canlet.2014.12.019","volume":"358","author":"WT Liu","year":"2015","unstructured":"Liu WT, et al. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma. Cancer Lett. 2015;358:136\u201343.","journal-title":"Cancer Lett"},{"key":"4720_CR101","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/abbs\/gmx100","volume":"49","author":"Y Lu","year":"2017","unstructured":"Lu Y, Xu J, Chen S, Zhou Z, Lin N. Lipopolysaccharide promotes angiogenesis in mice model of HCC by stimulating hepatic stellate cell activation via TLR4 pathway. Acta Biochim Biophys Sin (Shanghai). 2017;49:1029\u201334.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"4720_CR102","doi-asserted-by":"publisher","first-page":"106101","DOI":"10.1016\/j.phrs.2022.106101","volume":"177","author":"S Guo","year":"2022","unstructured":"Guo S, et al. Downregulation of the farnesoid X receptor promotes colorectal tumorigenesis by facilitating enterotoxigenic Bacteroides fragilis colonization. Pharmacol Res. 2022;177:106101.","journal-title":"Pharmacol Res"},{"key":"4720_CR103","doi-asserted-by":"publisher","first-page":"e1011096","DOI":"10.1371\/journal.ppat.1011096","volume":"19","author":"Y Wu","year":"2023","unstructured":"Wu Y, et al. Fn-Dps, a novel virulence factor of Fusobacterium nucleatum, disrupts erythrocytes and promotes metastasis in colorectal cancer. PLoS Pathog. 2023;19:e1011096.","journal-title":"PLoS Pathog"},{"key":"4720_CR104","doi-asserted-by":"publisher","first-page":"107686","DOI":"10.1016\/j.isci.2023.107686","volume":"26","author":"M Zhang","year":"2023","unstructured":"Zhang M, et al. Fusobacterium nucleatum promotes colorectal cancer metastasis by excretion of miR-122-5p from cells via exosomes. iScience. 2023;26:107686.","journal-title":"iScience"},{"key":"4720_CR105","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1158\/0008-5472.CAN-21-0453","volume":"81","author":"C Kong","year":"2021","unstructured":"Kong C, et al. Fusobacterium Nucleatum Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450\/Epoxyoctadecenoic Acid Axis via TLR4\/Keap1\/NRF2 Signaling. Cancer Res. 2021;81:4485\u201398.","journal-title":"Cancer Res"},{"key":"4720_CR106","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1111\/febs.15233","volume":"287","author":"S Zhang","year":"2020","unstructured":"Zhang S, et al. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG\/miR-296-5p\/Akt2\/SNAI1 signaling pathway. Febs j. 2020;287:4032\u201347.","journal-title":"Febs j"},{"key":"4720_CR107","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/cmi.12211","volume":"16","author":"H Inaba","year":"2014","unstructured":"Inaba H, et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell Microbiol. 2014;16:131\u201345.","journal-title":"Cell Microbiol"},{"key":"4720_CR108","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00430-015-0389-y","volume":"204","author":"H Inaba","year":"2015","unstructured":"Inaba H, Amano A, Lamont RJ, Murakami Y. Involvement of protease-activated receptor 4 in over-expression of matrix metalloproteinase 9 induced by Porphyromonas gingivalis. Med Microbiol Immunol. 2015;204:605\u201312.","journal-title":"Med Microbiol Immunol"},{"key":"4720_CR109","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3389\/fcimb.2017.00493","volume":"7","author":"J Lee","year":"2017","unstructured":"Lee J, et al. Human Primary Epithelial Cells Acquire an Epithelial-Mesenchymal-Transition Phenotype during Long-Term Infection by the Oral Opportunistic Pathogen, Porphyromonas gingivalis. Front Cell Infect Microbiol. 2017;7:493.","journal-title":"Front Cell Infect Microbiol"},{"key":"4720_CR110","doi-asserted-by":"crossref","unstructured":"Baj J, et al. Mechanisms of the epithelial-mesenchymal transition and tumor microenvironment in helicobacter pylori-induced gastric cancer. Cells. 2020;9(4):1055.","DOI":"10.3390\/cells9041055"},{"key":"4720_CR111","doi-asserted-by":"publisher","first-page":"111127","DOI":"10.1016\/j.celrep.2022.111127","volume":"40","author":"X Lu","year":"2022","unstructured":"Lu X, et al. Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis. Cell Rep. 2022;40:111127.","journal-title":"Cell Rep"},{"key":"4720_CR112","doi-asserted-by":"crossref","unstructured":"Casasanta MA, et al. Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration. Sci Signal. 2020;13(641):eaba9157.","DOI":"10.1126\/scisignal.aba9157"},{"key":"4720_CR113","doi-asserted-by":"crossref","unstructured":"Y\u00e1\u00f1ez L, et al. Co-culture of P. gingivalis and F. nucleatum synergistically elevates IL-6 expression via TLR4 signaling in oral keratinocytes. Int J Mol Sci. 2024;25(7):3611.","DOI":"10.3390\/ijms25073611"},{"key":"4720_CR114","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ccell.2021.03.004","volume":"39","author":"A Bertocchi","year":"2021","unstructured":"Bertocchi A, et al. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver. Cancer Cell. 2021;39:708\u2013e724711.","journal-title":"Cancer Cell"},{"key":"4720_CR115","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s41467-022-28913-5","volume":"13","author":"S Chen","year":"2022","unstructured":"Chen S, et al. Fusobacterium nucleatum reduces METTL3-mediated m(6)A modification and contributes to colorectal cancer metastasis. Nat Commun. 2022;13:1248.","journal-title":"Nat Commun"},{"key":"4720_CR116","doi-asserted-by":"publisher","first-page":"2038852","DOI":"10.1080\/19490976.2022.2038852","volume":"14","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1\/NF-\u03baB\/ICAM1 axis. Gut Microbes. 2022;14:2038852.","journal-title":"Gut Microbes"},{"key":"4720_CR117","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.chom.2024.04.020","volume":"32","author":"C Li","year":"2024","unstructured":"Li C, et al. Enterococcus-derived tyramine hijacks \u03b1(2A)-adrenergic receptor in intestinal stem cells to exacerbate colitis. Cell Host Microbe. 2024;32:950\u2013e963958.","journal-title":"Cell Host Microbe"},{"key":"4720_CR118","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12964-024-01627-5","volume":"22","author":"YF Wei","year":"2024","unstructured":"Wei YF, et al. Helicobacter pylori disrupts gastric mucosal homeostasis by stimulating macrophages to secrete CCL3. Cell Commun Signal. 2024;22:263.","journal-title":"Cell Commun Signal"},{"key":"4720_CR119","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.1038\/s41467-023-40987-3","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma. Nat Commun. 2023;14:5788.","journal-title":"Nat Commun"},{"key":"4720_CR120","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/0008-5472.CAN-24-2580","volume":"85","author":"T Zhang","year":"2025","unstructured":"Zhang T, et al. Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion. Cancer Res. 2025;85:1819\u201341.","journal-title":"Cancer Res"},{"key":"4720_CR121","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1158\/2326-6066.CIR-22-0107","volume":"10","author":"R Peng","year":"2022","unstructured":"Peng R, et al. Gastric Microbiome Alterations Are Associated with Decreased CD8\u2009+\u2009Tissue-Resident Memory T Cells in the Tumor Microenvironment of Gastric Cancer. Cancer Immunol Res. 2022;10:1224\u201340.","journal-title":"Cancer Immunol Res"},{"key":"4720_CR122","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar S, et al. The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov. 2018;8:403\u201316.","journal-title":"Cancer Discov"},{"key":"4720_CR123","doi-asserted-by":"publisher","first-page":"104444","DOI":"10.1016\/j.ebiom.2023.104444","volume":"88","author":"J Sun","year":"2023","unstructured":"Sun J, et al. F. nucleatum facilitates oral squamous cell carcinoma progression via GLUT1-driven lactate production. EBioMedicine. 2023;88:104444.","journal-title":"EBioMedicine"},{"key":"4720_CR124","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur C, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42:344\u201355.","journal-title":"Immunity"},{"key":"4720_CR125","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1128\/IAI.68.4.1893-1898.2000","volume":"68","author":"A Jewett","year":"2000","unstructured":"Jewett A, et al. Induction of apoptotic cell death in peripheral blood mononuclear and polymorphonuclear cells by an oral bacterium, Fusobacterium nucleatum. Infect Immun. 2000;68:1893\u20138.","journal-title":"Infect Immun"},{"key":"4720_CR126","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41419-018-0389-0","volume":"9","author":"Y Xue","year":"2018","unstructured":"Xue Y, et al. Indoleamine 2,3-dioxygenase expression regulates the survival and proliferation of Fusobacterium nucleatum in THP-1-derived macrophages. Cell Death Dis. 2018;9:355.","journal-title":"Cell Death Dis"},{"key":"4720_CR127","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","volume":"40","author":"P Wu","year":"2014","unstructured":"Wu P, et al. \u03b3\u03b4T17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity. 2014;40:785\u2013800.","journal-title":"Immunity"},{"key":"4720_CR128","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","volume":"7","author":"TM Loo","year":"2017","unstructured":"Loo TM, et al. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE(2)-Mediated Suppression of Antitumor Immunity. Cancer Discov. 2017;7:522\u201338.","journal-title":"Cancer Discov"},{"key":"4720_CR129","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/gutjnl-2020-320777","volume":"70","author":"Y Yang","year":"2020","unstructured":"Yang Y, et al. Cross-talk between the gut microbiota and monocyte-like macrophages mediates an inflammatory response to promote colitis-associated tumourigenesis. Gut. 2020;70:1495\u2013506.","journal-title":"Gut"},{"key":"4720_CR130","doi-asserted-by":"publisher","first-page":"1980347","DOI":"10.1080\/19490976.2021.1980347","volume":"13","author":"C Xu","year":"2021","unstructured":"Xu C, et al. Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322\/CCL20 axis and M2 polarization. Gut Microbes. 2021;13:1980347.","journal-title":"Gut Microbes"},{"key":"4720_CR131","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41419-024-06640-7","volume":"15","author":"F Nie","year":"2024","unstructured":"Nie F, et al. The role of CXCL2-mediated crosstalk between tumor cells and macrophages in Fusobacterium nucleatum-promoted oral squamous cell carcinoma progression. Cell Death Dis. 2024;15:277.","journal-title":"Cell Death Dis"},{"key":"4720_CR132","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1111\/cas.15901","volume":"114","author":"M Hayashi","year":"2023","unstructured":"Hayashi M, et al. Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis. Cancer Sci. 2023;114:3666\u201378.","journal-title":"Cancer Sci"},{"key":"4720_CR133","doi-asserted-by":"crossref","unstructured":"Thiele Orberg E, et al. The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis. Mucosal Immunol. 2017;10:421\u201333.","DOI":"10.1038\/mi.2016.53"},{"key":"4720_CR134","doi-asserted-by":"publisher","first-page":"16189","DOI":"10.1038\/nmicrobiol.2016.189","volume":"2","author":"A Javaheri","year":"2016","unstructured":"Javaheri A, et al. Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. Nat Microbiol. 2016;2:16189.","journal-title":"Nat Microbiol"},{"key":"4720_CR135","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1158\/0008-5472.CAN-09-2755","volume":"70","author":"T Niwa","year":"2010","unstructured":"Niwa T, et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 2010;70:1430\u201340.","journal-title":"Cancer Res"},{"key":"4720_CR136","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.cell.2024.01.004","volume":"187","author":"K Fu","year":"2024","unstructured":"Fu K, et al. Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice. Cell. 2024;187:882\u2013e896817.","journal-title":"Cell"},{"key":"4720_CR137","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14:195\u2013206.","journal-title":"Cell Host Microbe"},{"key":"4720_CR138","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/ibd\/izac177","volume":"29","author":"S Wei","year":"2023","unstructured":"Wei S, et al. Fusobacterium nucleatum Extracellular Vesicles Promote Experimental Colitis by Modulating Autophagy via the miR-574-5p\/CARD3 Axis. Inflamm Bowel Dis. 2023;29:9\u201326.","journal-title":"Inflamm Bowel Dis"},{"key":"4720_CR139","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1902\/jop.2010.100458","volume":"82","author":"H Mahtout","year":"2011","unstructured":"Mahtout H, Chandad F, Rojo JM, Grenier D. Fusobacterium nucleatum binding to complement regulatory protein CD46 modulates the expression and secretion of cytokines and matrix metalloproteinases by oral epithelial cells. J Periodontol. 2011;82:311\u20139.","journal-title":"J Periodontol"},{"key":"4720_CR140","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1128\/IAI.02000-14","volume":"82","author":"H Wang","year":"2014","unstructured":"Wang H, et al. Porphyromonas gingivalis-induced reactive oxygen species activate JAK2 and regulate production of inflammatory cytokines through c-Jun. Infect Immun. 2014;82:4118\u201326.","journal-title":"Infect Immun"},{"key":"4720_CR141","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1136\/gutjnl-2024-334604","volume":"74","author":"Y Sun","year":"2025","unstructured":"Sun Y, et al. Enterococcus faecalis hijacks FABP2 to activate quorum-sensing signals and aggravate Crohn\u2019s disease by inducing gut dysbiosis. Gut. 2025;74:1962\u201376.","journal-title":"Gut"},{"key":"4720_CR142","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/cmi.12497","volume":"18","author":"BJ Shenker","year":"2016","unstructured":"Shenker BJ, et al. The toxicity of the Aggregatibacter actinomycetemcomitans cytolethal distending toxin correlates with its phosphatidylinositol-3,4,5-triphosphate phosphatase activity. Cell Microbiol. 2016;18:223\u201343.","journal-title":"Cell Microbiol"},{"key":"4720_CR143","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1053\/j.gastro.2021.08.003","volume":"161","author":"Y Cao","year":"2021","unstructured":"Cao Y, et al. Enterotoxigenic Bacteroidesfragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p. Gastroenterology. 2021;161:1552\u2013e15661512.","journal-title":"Gastroenterology"},{"key":"4720_CR144","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1128\/IAI.01140-12","volume":"82","author":"Y Fujita","year":"2014","unstructured":"Fujita Y, et al. Hemoglobin receptor protein from Porphyromonas gingivalis induces interleukin-8 production in human gingival epithelial cells through stimulation of the mitogen-activated protein kinase and NF-\u03baB signal transduction pathways. Infect Immun. 2014;82:202\u201311.","journal-title":"Infect Immun"},{"key":"4720_CR145","doi-asserted-by":"publisher","first-page":"2073785","DOI":"10.1080\/19490976.2022.2073785","volume":"14","author":"Q Tan","year":"2022","unstructured":"Tan Q, et al. Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils. Gut Microbes. 2022;14:2073785.","journal-title":"Gut Microbes"},{"key":"4720_CR146","doi-asserted-by":"publisher","first-page":"101942","DOI":"10.1016\/j.bpg.2024.101942","volume":"72","author":"N Grellier","year":"2024","unstructured":"Grellier N, et al. Gut microbiota in inflammation and colorectal cancer: A potential Toolbox for Clinicians. Best Pract Res Clin Gastroenterol. 2024;72:101942.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"4720_CR147","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5217\/ir.2016.14.3.202","volume":"14","author":"RJ Colman","year":"2016","unstructured":"Colman RJ, Rubin DT. Histological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic review. Intest Res. 2016;14:202\u201310.","journal-title":"Intest Res"},{"key":"4720_CR148","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41579-023-00973-4","volume":"22","author":"MT White","year":"2024","unstructured":"White MT, Sears CL. The microbial landscape of colorectal cancer. Nat Rev Microbiol. 2024;22:240\u201354.","journal-title":"Nat Rev Microbiol"},{"key":"4720_CR149","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41467-025-67047-2","volume":"17","author":"Z Shi","year":"2025","unstructured":"Shi Z, et al. Tissue-resident microbiota impacts colorectal cancer progression and prognosis. Nat Commun. 2025;17:346.","journal-title":"Nat Commun"},{"key":"4720_CR150","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMsb2515372","volume":"394","author":"JY Park","year":"2026","unstructured":"Park JY, et al. Helicobacter pylori Screen-and-Treat Programs for Gastric Cancer Prevention - IARC Working Group Report. N Engl J Med. 2026;394:1131\u20137.","journal-title":"N Engl J Med"},{"key":"4720_CR151","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1136\/gutjnl-2020-320839","volume":"69","author":"AC Ford","year":"2020","unstructured":"Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020;69:2113\u201321.","journal-title":"Gut"},{"key":"4720_CR152","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2147\/IDR.S232982","volume":"13","author":"A Barzegari","year":"2020","unstructured":"Barzegari A, et al. The Battle of Probiotics and Their Derivatives Against Biofilms. Infect Drug Resist. 2020;13:659\u201372.","journal-title":"Infect Drug Resist"},{"key":"4720_CR153","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41538-024-00339-x","volume":"8","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. Akkermansia muciniphila ONE effectively ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis in mice. NPJ Sci Food. 2024;8:97.","journal-title":"NPJ Sci Food"},{"key":"4720_CR154","doi-asserted-by":"publisher","first-page":"102026","DOI":"10.1016\/j.cdnut.2023.102026","volume":"7","author":"R Abdulqadir","year":"2023","unstructured":"Abdulqadir R, Engers J, Al-Sadi R. Role of Bifidobacterium in Modulating the Intestinal Epithelial Tight Junction Barrier: Current Knowledge and Perspectives. Curr Dev Nutr. 2023;7:102026.","journal-title":"Curr Dev Nutr"},{"key":"4720_CR155","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","volume":"28","author":"L Derosa","year":"2022","unstructured":"Derosa L, et al. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nat Med. 2022;28:315\u201324.","journal-title":"Nat Med"},{"key":"4720_CR156","doi-asserted-by":"crossref","unstructured":"Ding S, Hu C, Fang J, Liu G. The Protective Role of Probiotics against Colorectal Cancer. Oxid Med Cell Longev 2020, 8884583 (2020).","DOI":"10.1155\/2020\/8884583"},{"key":"4720_CR157","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.canlet.2019.11.019","volume":"469","author":"D Chen","year":"2020","unstructured":"Chen D, et al. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett. 2020;469:456\u201367.","journal-title":"Cancer Lett"},{"key":"4720_CR158","doi-asserted-by":"publisher","first-page":"1380713","DOI":"10.3389\/fphys.2024.1380713","volume":"15","author":"TR Dmytriv","year":"2024","unstructured":"Dmytriv TR, Storey KB, Lushchak VI. Intestinal barrier permeability: the influence of gut microbiota, nutrition, and exercise. Front Physiol. 2024;15:1380713.","journal-title":"Front Physiol"},{"key":"4720_CR159","first-page":"689","volume":"73","author":"BR Goldin","year":"1984","unstructured":"Goldin BR, Gorbach SL. Alterations of the intestinal microflora by diet, oral antibiotics, and Lactobacillus: decreased production of free amines from aromatic nitro compounds, azo dyes, and glucuronides. J Natl Cancer Inst. 1984;73:689\u201395.","journal-title":"J Natl Cancer Inst"},{"key":"4720_CR160","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.ccell.2025.07.012","volume":"43","author":"M Xie","year":"2025","unstructured":"Xie M, et al. Tumor-resident probiotic Clostridium butyricum improves aPD-1 efficacy in colorectal cancer models by inhibiting IL-6-mediated immunosuppression. Cancer Cell. 2025;43:1885\u2013e19011810.","journal-title":"Cancer Cell"},{"key":"4720_CR161","doi-asserted-by":"crossref","unstructured":"Ma C, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360(6391):eaan5931.","DOI":"10.1126\/science.aan5931"},{"key":"4720_CR162","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","volume":"18","author":"S Salminen","year":"2021","unstructured":"Salminen S, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18:649\u201367.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4720_CR163","doi-asserted-by":"publisher","first-page":"2483780","DOI":"10.1080\/19490976.2025.2483780","volume":"17","author":"B Thulasinathan","year":"2025","unstructured":"Thulasinathan B, et al. The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention. Gut Microbes. 2025;17:2483780.","journal-title":"Gut Microbes"},{"key":"4720_CR164","doi-asserted-by":"crossref","unstructured":"Sun J, et al. Butyrate as a promising therapeutic target in cancer: from pathogenesis to clinic (Review). Int J Oncol. 2024;64(4):44.","DOI":"10.3892\/ijo.2024.5632"},{"key":"4720_CR165","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10059-012-2266-5","volume":"33","author":"H Kim","year":"2012","unstructured":"Kim H, et al. Lactobacillus plantarum lipoteichoic acid alleviates TNF-\u03b1-induced inflammation in the HT-29 intestinal epithelial cell line. Mol Cells. 2012;33:479\u201386.","journal-title":"Mol Cells"},{"key":"4720_CR166","doi-asserted-by":"publisher","first-page":"664395","DOI":"10.3389\/fmicb.2021.664395","volume":"12","author":"AK Abdalla","year":"2021","unstructured":"Abdalla AK, et al. Exopolysaccharides as Antimicrobial Agents: Mechanism and Spectrum of Activity. Front Microbiol. 2021;12:664395.","journal-title":"Front Microbiol"},{"key":"4720_CR167","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41575-020-00375-4","volume":"18","author":"SK Gill","year":"2021","unstructured":"Gill SK, Rossi M, Bajka B, Whelan K. Dietary fibre in gastrointestinal health and disease. Nat Rev Gastroenterol Hepatol. 2021;18:101\u201316.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4720_CR168","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40168-022-01248-5","volume":"10","author":"EC Deehan","year":"2022","unstructured":"Deehan EC, et al. Elucidating the role of the gut microbiota in the physiological effects of dietary fiber. Microbiome. 2022;10:77.","journal-title":"Microbiome"},{"key":"4720_CR169","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.1080\/10408398.2024.2436644","volume":"65","author":"T Mao","year":"2025","unstructured":"Mao T, Zhang Y, Kaushik R, Mohan MS. Effects of polyphenols on gut microbiota and inflammatory markers in individuals with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2025;65:6158\u201375.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4720_CR170","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40813-022-00264-z","volume":"8","author":"R Saleri","year":"2022","unstructured":"Saleri R, et al. Effects of different short-chain fatty acids (SCFA) on gene expression of proteins involved in barrier function in IPEC-J2. Porcine Health Manag. 2022;8:21.","journal-title":"Porcine Health Manag"},{"key":"4720_CR171","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.aaz7015","volume":"374","author":"CN Spencer","year":"2021","unstructured":"Spencer CN, et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science. 2021;374:1632\u201340.","journal-title":"Science"},{"key":"4720_CR172","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3892\/ol.2020.12404","volume":"21","author":"C Duan","year":"2021","unstructured":"Duan C, et al. L-fucose ameliorates the carcinogenic properties of Fusobacterium nucleatum in colorectal cancer. Oncol Lett. 2021;21:143.","journal-title":"Oncol Lett"},{"key":"4720_CR173","doi-asserted-by":"publisher","first-page":"109838","DOI":"10.1016\/j.jnutbio.2025.109838","volume":"139","author":"H Zeng","year":"2025","unstructured":"Zeng H, Safratowich BD, Liu Z, Bukowski MR. Resistant starch inhibits high-fat diet-induced oncogenic responses in the colon of C57BL\/6 mice. J Nutr Biochem. 2025;139:109838.","journal-title":"J Nutr Biochem"},{"key":"4720_CR174","doi-asserted-by":"crossref","unstructured":"Weber AM, et al. Integrated microbiota and metabolite changes following rice bran intake during murine inflammatory colitis-associated colon cancer and in colorectal cancer survivors. Cancers (Basel). 2023;15(8):2231.","DOI":"10.3390\/cancers15082231"},{"key":"4720_CR175","doi-asserted-by":"publisher","first-page":"1104224","DOI":"10.3389\/fimmu.2023.1104224","volume":"14","author":"E Boucher","year":"2023","unstructured":"Boucher E, et al. Inulin prebiotic reinforces host cancer immunosurveillance via \u0263\u03b4 T cell activation. Front Immunol. 2023;14:1104224.","journal-title":"Front Immunol"},{"key":"4720_CR176","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.trecan.2021.02.005","volume":"7","author":"AE Chang","year":"2021","unstructured":"Chang AE, et al. Targeting the Gut Microbiome to Mitigate Immunotherapy-Induced Colitis in Cancer. Trends Cancer. 2021;7:583\u201393.","journal-title":"Trends Cancer"},{"key":"4720_CR177","doi-asserted-by":"crossref","unstructured":"Zhou J, et al. An inulin-type fructan CP-A from codonopsis pilosula alleviated 5-fluorouracil-induced intestinal mucositis via the ERK\/MLCK\/MLC2 pathway and regulation of gut microbiota. Pharmaceuticals (Basel). 2024;17(3):297.","DOI":"10.3390\/ph17030297"},{"key":"4720_CR178","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12866-024-03384-4","volume":"24","author":"J Ziemons","year":"2024","unstructured":"Ziemons J, et al. Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon. BMC Microbiol. 2024;24:222.","journal-title":"BMC Microbiol"},{"key":"4720_CR179","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10555-023-10117-y","volume":"42","author":"MA Feitelson","year":"2023","unstructured":"Feitelson MA, Arzumanyan A, Medhat A, Spector I. Short-chain fatty acids in cancer pathogenesis. Cancer Metastasis Rev. 2023;42:677\u201398.","journal-title":"Cancer Metastasis Rev"},{"key":"4720_CR180","doi-asserted-by":"publisher","first-page":"129216","DOI":"10.1016\/j.ijbiomac.2024.129216","volume":"259","author":"E Ghali","year":"2024","unstructured":"Ghali E, Pranav, Chauhan SC, Yallapu MM. Inulin-based formulations as an emerging therapeutic strategy for cancer: A comprehensive review. Int J Biol Macromol. 2024;259:129216.","journal-title":"Int J Biol Macromol"},{"key":"4720_CR181","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ejcn.2015.192","volume":"70","author":"P Garcia-Peris","year":"2016","unstructured":"Garcia-Peris P, et al. Effect of inulin and fructo-oligosaccharide on the prevention of acute radiation enteritis in patients with gynecological cancer and impact on quality-of-life: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr. 2016;70:170\u20134.","journal-title":"Eur J Clin Nutr"},{"key":"4720_CR182","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10350-004-6257-2","volume":"45","author":"CF Welters","year":"2002","unstructured":"Welters CF, et al. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum. 2002;45:621\u20137.","journal-title":"Dis Colon Rectum"},{"key":"4720_CR183","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijbiomac.2022.01.166","volume":"204","author":"H Zhang","year":"2022","unstructured":"Zhang H, et al. Modulatory effects of polysaccharides from plants, marine algae and edible mushrooms on gut microbiota and related health benefits: A review. Int J Biol Macromol. 2022;204:169\u201392.","journal-title":"Int J Biol Macromol"},{"key":"4720_CR184","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1080\/10408398.2022.2139222","volume":"64","author":"M Vaghari-Tabari","year":"2024","unstructured":"Vaghari-Tabari M, et al. Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects? Crit Rev Food Sci Nutr. 2024;64:4155\u201378.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4720_CR185","doi-asserted-by":"publisher","first-page":"689456","DOI":"10.3389\/fnut.2021.689456","volume":"8","author":"MC Rodr\u00edguez-Daza","year":"2021","unstructured":"Rodr\u00edguez-Daza MC, et al. Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further. Front Nutr. 2021;8:689456.","journal-title":"Front Nutr"},{"key":"4720_CR186","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.3389\/fmicb.2017.02635","volume":"8","author":"HT Yang","year":"2017","unstructured":"Yang HT, et al. Lauric Acid Is an Inhibitor of Clostridium difficile Growth in Vitro and Reduces Inflammation in a Mouse Infection Model. Front Microbiol. 2017;8:2635.","journal-title":"Front Microbiol"},{"key":"4720_CR187","doi-asserted-by":"publisher","first-page":"582779","DOI":"10.3389\/fmicb.2020.582779","volume":"11","author":"Y Huan","year":"2020","unstructured":"Huan Y, Kong Q, Mou H, Yi H. Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields. Front Microbiol. 2020;11:582779.","journal-title":"Front Microbiol"},{"key":"4720_CR188","doi-asserted-by":"publisher","first-page":"e243812","DOI":"10.1001\/jamanetworkopen.2024.3812","volume":"7","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, et al. Anti-Helicobacter pylori Treatment in Patients With Gastric Cancer After Radical Gastrectomy. JAMA Netw Open. 2024;7:e243812.","journal-title":"JAMA Netw Open"},{"key":"4720_CR189","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","volume":"31","author":"SS Jiang","year":"2023","unstructured":"Jiang SS, et al. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer. Cell Host Microbe. 2023;31:781\u2013e797789.","journal-title":"Cell Host Microbe"},{"key":"4720_CR190","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1126\/science.aal5240","volume":"358","author":"S Bullman","year":"2017","unstructured":"Bullman S, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science. 2017;358:1443\u20138.","journal-title":"Science"},{"key":"4720_CR191","doi-asserted-by":"publisher","first-page":"e1067","DOI":"10.1002\/iid3.1067","volume":"11","author":"M Wang","year":"2023","unstructured":"Wang M, et al. Effects of metronidazole on colorectal cancer occurrence and colorectal cancer liver metastases by regulating Fusobacterium nucleatum in mice. Immun Inflamm Dis. 2023;11:e1067.","journal-title":"Immun Inflamm Dis"},{"key":"4720_CR192","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/infdis\/jiw069","volume":"214","author":"CE DeStefano Shields","year":"2016","unstructured":"DeStefano Shields CE, et al. Reduction of Murine Colon Tumorigenesis Driven by Enterotoxigenic Bacteroides fragilis Using Cefoxitin Treatment. J Infect Dis. 2016;214:122\u20139.","journal-title":"J Infect Dis"},{"key":"4720_CR193","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3389\/fimmu.2020.01380","volume":"11","author":"J Han","year":"2020","unstructured":"Han J, et al. Beneficial Effect of Antibiotics and Microbial Metabolites on Expanded V\u03b42V\u03b39 T Cells in Hepatocellular Carcinoma Immunotherapy. Front Immunol. 2020;11:1380.","journal-title":"Front Immunol"},{"key":"4720_CR194","doi-asserted-by":"publisher","first-page":"e0221964","DOI":"10.1371\/journal.pone.0221964","volume":"14","author":"L Lu","year":"2019","unstructured":"Lu L, et al. Association of antibiotic exposure with the mortality in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy: A hospital-based retrospective cohort study. PLoS ONE. 2019;14:e0221964.","journal-title":"PLoS ONE"},{"key":"4720_CR195","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357:1156\u201360.","journal-title":"Science"},{"key":"4720_CR196","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2147\/CMAR.S353432","volume":"14","author":"H Imai","year":"2022","unstructured":"Imai H, et al. Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study. Cancer Manag Res. 2022;14:1259\u201366.","journal-title":"Cancer Manag Res"},{"key":"4720_CR197","doi-asserted-by":"crossref","unstructured":"Imai H, et al. Antibiotics improve the treatment efficacy of oxaliplatin-based but not irinotecan-based therapy in advanced colorectal cancer patients. J Oncol. 2020;2020:1701326.","DOI":"10.1155\/2020\/1701326"},{"key":"4720_CR198","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jcmgh.2021.08.013","volume":"13","author":"A Smet","year":"2022","unstructured":"Smet A, Kupcinskas J, Link A, Hold GL, Bornschein J. The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse? Cell Mol Gastroenterol Hepatol. 2022;13:857\u201374.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4720_CR199","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/jnci\/djab125","volume":"114","author":"SSM Lu","year":"2022","unstructured":"Lu SSM, et al. Antibiotics Use and Subsequent Risk of Colorectal Cancer: A Swedish Nationwide Population-Based Study. J Natl Cancer Inst. 2022;114:38\u201346.","journal-title":"J Natl Cancer Inst"},{"key":"4720_CR200","doi-asserted-by":"crossref","unstructured":"Villegas I, et al. Amoxicillin and clarithromycin mucoadhesive delivery system for Helicobacter pylori infection in a mouse model: characterization, pharmacokinetics, and efficacy. Pharmaceutics. 2021;13(2):153.","DOI":"10.3390\/pharmaceutics13020153"},{"issue":"Suppl 1","key":"4720_CR201","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1073\/pnas.1000087107","volume":"108","author":"L Dethlefsen","year":"2011","unstructured":"Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4554\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4720_CR202","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1038\/s41467-023-41329-z","volume":"14","author":"K Wortelboer","year":"2023","unstructured":"Wortelboer K, et al. Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety. Nat Commun. 2023;14:5600.","journal-title":"Nat Commun"},{"key":"4720_CR203","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40168-024-01820-1","volume":"12","author":"TS Rasmussen","year":"2024","unstructured":"Rasmussen TS, et al. Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments. Microbiome. 2024;12:119.","journal-title":"Microbiome"},{"key":"4720_CR204","doi-asserted-by":"publisher","first-page":"9107","DOI":"10.1038\/s41598-019-45549-6","volume":"9","author":"M Kabwe","year":"2019","unstructured":"Kabwe M, et al. Genomic, morphological and functional characterisation of novel bacteriophage FNU1 capable of disrupting Fusobacterium nucleatum biofilms. Sci Rep. 2019;9:9107.","journal-title":"Sci Rep"},{"key":"4720_CR205","doi-asserted-by":"crossref","unstructured":"Lam HYP, et al. A novel bacteriophage with the potential to inhibit Fusobacterium nucleatum-induced proliferation of colorectal cancer cells. Antibiot (Basel). 2025;14(1):45.","DOI":"10.3390\/antibiotics14010045"},{"key":"4720_CR206","doi-asserted-by":"crossref","unstructured":"Kabwe M, Ayelign B, Afshar-Sterle S, Buchert M, Tucci J. Bacteriophage FNU1 negates Fusobacterium nucleatum induced cell growth, migration and chemotherapy resistance in gastrointestinal cancer cells. Front Cell Infect Microbiol. 2025;15:1721411.","DOI":"10.3389\/fcimb.2025.1721411"},{"key":"4720_CR207","doi-asserted-by":"publisher","first-page":"650849","DOI":"10.3389\/fmicb.2021.650849","volume":"12","author":"M Kabwe","year":"2021","unstructured":"Kabwe M, et al. Lytic Bacteriophage EFA1 Modulates HCT116 Colon Cancer Cell Growth and Upregulates ROS Production in an Enterococcus faecalis Co-culture System. Front Microbiol. 2021;12:650849.","journal-title":"Front Microbiol"},{"key":"4720_CR208","doi-asserted-by":"crossref","unstructured":"El-Telbany M, et al. Bacteriophages to control multi-drug resistant enterococcus faecalis infection of dental root canals. Microorganisms. 2021;9(3):517.","DOI":"10.3390\/microorganisms9030517"},{"key":"4720_CR209","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12866-023-03040-3","volume":"23","author":"P Mondal","year":"2023","unstructured":"Mondal P, et al. Controlling the bacterial load of Salmonella Typhi in an experimental mouse model by a lytic Salmonella phage STWB21: a phage therapy approach. BMC Microbiol. 2023;23:324.","journal-title":"BMC Microbiol"},{"key":"4720_CR210","doi-asserted-by":"crossref","unstructured":"Islam MS, et al. Characterization of salmonella phage LPST153 that effectively targets most prevalent salmonella serovars. Microorganisms. 2020;8(7):1089.","DOI":"10.3390\/microorganisms8071089"},{"key":"4720_CR211","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.chom.2025.05.004","volume":"33","author":"X Ding","year":"2025","unstructured":"Ding X, et al. Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity. Cell Host Microbe. 2025;33:941\u2013e956910.","journal-title":"Cell Host Microbe"},{"key":"4720_CR212","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.anaerobe.2013.05.001","volume":"22","author":"E Meader","year":"2013","unstructured":"Meader E, Mayer MJ, Steverding D, Carding SR, Narbad A. Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system. Anaerobe. 2013;22:25\u201330.","journal-title":"Anaerobe"},{"key":"4720_CR213","doi-asserted-by":"crossref","unstructured":"Ferreira R, et al. Characterization and genomic analysis of a new phage infecting Helicobacter pylori. Int J Mol Sci. 2022;23(14):7885.","DOI":"10.3390\/ijms23147885"},{"key":"4720_CR214","doi-asserted-by":"publisher","first-page":"549084","DOI":"10.3389\/fmicb.2020.549084","volume":"11","author":"AB Mu\u00f1oz","year":"2020","unstructured":"Mu\u00f1oz AB, Stepanian J, Trespalacios AA, Vale FF. Bacteriophages of Helicobacter pylori. Front Microbiol. 2020;11:549084.","journal-title":"Front Microbiol"},{"key":"4720_CR215","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","volume":"575","author":"Y Duan","year":"2019","unstructured":"Duan Y, et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019;575:505\u201311.","journal-title":"Nature"},{"key":"4720_CR216","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1038\/s41467-023-39028-w","volume":"14","author":"L Gan","year":"2023","unstructured":"Gan L, et al. Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae. Nat Commun. 2023;14:3215.","journal-title":"Nat Commun"},{"key":"4720_CR217","doi-asserted-by":"publisher","first-page":"e2401611","DOI":"10.1002\/smtd.202401611","volume":"9","author":"X Hou","year":"2025","unstructured":"Hou X, et al. Advances in Engineered Phages for Disease Treatment. Small Methods. 2025;9:e2401611.","journal-title":"Small Methods"},{"key":"4720_CR218","doi-asserted-by":"publisher","first-page":"e2307111","DOI":"10.1002\/smll.202307111","volume":"20","author":"XT Li","year":"2024","unstructured":"Li XT, et al. Recent Progress in Phage-Based Nanoplatforms for Tumor Therapy. Small. 2024;20:e2307111.","journal-title":"Small"},{"key":"4720_CR219","doi-asserted-by":"publisher","first-page":"1419568","DOI":"10.3389\/fcimb.2024.1419568","volume":"14","author":"L Hochvaldova","year":"2024","unstructured":"Hochvaldova L, Posselt G, Wessler S, Kv\u00edtek L, Pan\u00e1\u010dek A. Implications of silver nanoparticles for H. pylori infection: modulation of CagA function and signaling. Front Cell Infect Microbiol. 2024;14:1419568.","journal-title":"Front Cell Infect Microbiol"},{"key":"4720_CR220","first-page":"17","volume":"23","author":"R Ve\u010de\u0159ov\u00e1","year":"2017","unstructured":"Ve\u010de\u0159ov\u00e1 R, Pan\u00e1\u010dek A, Kol\u00e1\u0159 M. [Effect of silver nanoparticles on anaerobic bacteria]. Klin Mikrobiol Infekc Lek. 2017;23:17\u201320.","journal-title":"Klin Mikrobiol Infekc Lek"},{"key":"4720_CR221","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s12011-012-9410-0","volume":"149","author":"MQ Wang","year":"2012","unstructured":"Wang MQ, et al. Effects of copper-loaded chitosan nanoparticles on intestinal microflora and morphology in weaned piglets. Biol Trace Elem Res. 2012;149:184\u20139.","journal-title":"Biol Trace Elem Res"},{"key":"4720_CR222","doi-asserted-by":"publisher","first-page":"105201","DOI":"10.1016\/j.ibiod.2021.105201","volume":"159","author":"M Naseer","year":"2021","unstructured":"Naseer M, Ramadan R, Xing J, Samak NA. Facile green synthesis of copper oxide nanoparticles for the eradication of multidrug resistant Klebsiella pneumonia and Helicobacter pylori biofilms. Int Biodeterior Biodegrad. 2021;159:105201.","journal-title":"Int Biodeterior Biodegrad"},{"key":"4720_CR223","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.1039\/D2DT00328G","volume":"51","author":"K Stokowa-So\u0142tys","year":"2022","unstructured":"Stokowa-So\u0142tys K, Kierpiec K, Wieczorek R. Might Cu(II) binding, DNA cleavage and radical production by YadA fragments be involved in the promotion of F. nucleatum related cancers? Dalton Trans. 2022;51:7040\u201352.","journal-title":"Dalton Trans"},{"key":"4720_CR224","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/14656566.2022.2150545","volume":"24","author":"M Sakashita","year":"2023","unstructured":"Sakashita M, Nangaku M. Ferumoxytol: an emerging therapeutic for iron deficiency anemia. Expert Opin Pharmacother. 2023;24:171\u20135.","journal-title":"Expert Opin Pharmacother"},{"key":"4720_CR225","doi-asserted-by":"publisher","first-page":"8124","DOI":"10.1038\/s41598-017-08387-y","volume":"7","author":"WT Lee","year":"2017","unstructured":"Lee WT, et al. Octahedron Iron Oxide Nanocrystals Prohibited Clostridium difficile Spore Germination and Attenuated Local and Systemic Inflammation. Sci Rep. 2017;7:8124.","journal-title":"Sci Rep"},{"key":"4720_CR226","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jphotobiol.2015.02.008","volume":"146","author":"PC Nagajyothi","year":"2015","unstructured":"Nagajyothi PC, et al. Antioxidant and anti-inflammatory activities of zinc oxide nanoparticles synthesized using Polygala tenuifolia root extract. J Photochem Photobiol B. 2015;146:10\u20137.","journal-title":"J Photochem Photobiol B"},{"key":"4720_CR227","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1002\/cai2.150","volume":"3","author":"A Kumar","year":"2024","unstructured":"Kumar A, et al. Impact of metallic nanoparticles on gut microbiota modulation in colorectal cancer: A review. Cancer Innov. 2024;3:e150.","journal-title":"Cancer Innov"},{"key":"4720_CR228","doi-asserted-by":"publisher","first-page":"11789","DOI":"10.1039\/C8NR08442D","volume":"11","author":"Y Hu","year":"2019","unstructured":"Hu Y, et al. Enhancing tumor chemotherapy and overcoming drug resistance through autophagy-mediated intracellular dissolution of zinc oxide nanoparticles. Nanoscale. 2019;11:11789\u2013807.","journal-title":"Nanoscale"},{"key":"4720_CR229","doi-asserted-by":"publisher","first-page":"tfad127","DOI":"10.1093\/toxres\/tfad127","volume":"13","author":"F Motafeghi","year":"2024","unstructured":"Motafeghi F, Mortazavi P, Shokrzadeh M. Anticancer activity of zinc oxide nanoparticles on prostate and colon cancer cell line. Toxicol Res (Camb). 2024;13:tfad127.","journal-title":"Toxicol Res (Camb)"},{"key":"4720_CR230","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12645-023-00195-6","volume":"14","author":"L Racca","year":"2023","unstructured":"Racca L, et al. Effective combination of biocompatible zinc oxide nanocrystals and high-energy shock waves for the treatment of colorectal cancer. Cancer Nanotechnol. 2023;14:37.","journal-title":"Cancer Nanotechnol"},{"key":"4720_CR231","doi-asserted-by":"crossref","unstructured":"Kobos L, et al. Biocorona-induced modifications in engineered nanomaterial-cellular interactions impacting biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12:e1608.","DOI":"10.1002\/wnan.1608"},{"key":"4720_CR232","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41565-017-0013-y","volume":"13","author":"A Pan\u00e1\u010dek","year":"2018","unstructured":"Pan\u00e1\u010dek A, et al. Bacterial resistance to silver nanoparticles and how to overcome it. Nat Nanotechnol. 2018;13:65\u201371.","journal-title":"Nat Nanotechnol"},{"key":"4720_CR233","doi-asserted-by":"crossref","unstructured":"Ortega VA, et al. Polymer-coated nanoparticle protein corona formation potentiates phagocytosis of bacteria by innate immune cells and inhibits coagulation in human plasma. Biointerphases. 2020;15:051003.","DOI":"10.1116\/6.0000385"},{"key":"4720_CR234","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.scitotenv.2018.09.312","volume":"651","author":"N Yin","year":"2019","unstructured":"Yin N, et al. Formation of silver nanoparticles by human gut microbiota. Sci Total Environ. 2019;651:1489\u201394.","journal-title":"Sci Total Environ"},{"key":"4720_CR235","doi-asserted-by":"crossref","unstructured":"Gudkov SV, Burmistrov DE, Fomina PA, Validov SZ, Kozlov VA. Antibacterial properties of copper oxide nanoparticles (review). Int J Mol Sci. 2024;25(21):11563.","DOI":"10.3390\/ijms252111563"},{"key":"4720_CR236","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.fct.2016.04.014","volume":"93","author":"IM Urrutia-Ortega","year":"2016","unstructured":"Urrutia-Ortega IM, et al. Food-grade titanium dioxide exposure exacerbates tumor formation in colitis associated cancer model. Food Chem Toxicol. 2016;93:20\u201331.","journal-title":"Food Chem Toxicol"},{"key":"4720_CR237","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.addr.2020.06.025","volume":"163\u2013164","author":"F Soetaert","year":"2020","unstructured":"Soetaert F, Korangath P, Serantes D, Fiering S, Ivkov R. Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies. Adv Drug Deliv Rev. 2020;163\u2013164:65\u201383.","journal-title":"Adv Drug Deliv Rev"},{"key":"4720_CR238","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fnut.2019.00057","volume":"6","author":"G Pinget","year":"2019","unstructured":"Pinget G, et al. Impact of the Food Additive Titanium Dioxide (E171) on Gut Microbiota-Host Interaction. Front Nutr. 2019;6:57.","journal-title":"Front Nutr"},{"key":"4720_CR239","doi-asserted-by":"crossref","unstructured":"Pandey S, De Klerk C, Kim J, Kang M, Fosso-Kankeu E. Eco friendly approach for synthesis, characterization and biological activities of milk protein stabilized silver nanoparticles. Polym (Basel). 2020;12(6):1418.","DOI":"10.3390\/polym12061418"},{"key":"4720_CR240","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12903-016-0201-4","volume":"16","author":"M Reise","year":"2016","unstructured":"Reise M, et al. Antibacterial effect of silver (I) carbohydrate complexes on oral pathogenic key species in vitro. BMC Oral Health. 2016;16:42.","journal-title":"BMC Oral Health"},{"key":"4720_CR241","doi-asserted-by":"crossref","unstructured":"Lazi\u0107 V, Nik\u0161i\u0107 V, Nedeljkovi\u0107 JM. Application of TiO(2) in photocatalytic bacterial inactivation: review. Int J Mol Sci. 2025;26(21):10593.","DOI":"10.3390\/ijms262110593"},{"key":"4720_CR242","doi-asserted-by":"publisher","first-page":"e70776","DOI":"10.1371\/journal.pone.0070776","volume":"8","author":"S Chakraborti","year":"2013","unstructured":"Chakraborti S, Bhattacharya S, Chowdhury R, Chakrabarti P. The molecular basis of inactivation of metronidazole-resistant Helicobacter pylori using polyethyleneimine functionalized zinc oxide nanoparticles. PLoS ONE. 2013;8:e70776.","journal-title":"PLoS ONE"},{"key":"4720_CR243","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.1002\/agt2.423","volume":"5","author":"R Liu","year":"2024","unstructured":"Liu R, et al. Photodynamic eradication of intratumoral microbiota with bacteria-targeted micelles overcomes gemcitabine resistance of pancreatic cancer. Aggregate. 2024;5:e423.","journal-title":"Aggregate"},{"key":"4720_CR244","first-page":"14164","volume":"15","author":"X Li","year":"2023","unstructured":"Li X, Ma Y, Xin Y, Ma F, Gao H. Tumor-Targeting Nanoassembly for Enhanced Colorectal Cancer Therapy by Eliminating Intratumoral Fusobacterium nucleatum. ACS Appl Mater Interfaces. 2023;15:14164\u201372.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4720_CR245","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.colsurfb.2018.01.008","volume":"164","author":"M Luo","year":"2018","unstructured":"Luo M, et al. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori. Colloids Surf B Biointerfaces. 2018;164:11\u20139.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4720_CR246","doi-asserted-by":"publisher","first-page":"e1903793","DOI":"10.1002\/adma.201903793","volume":"31","author":"Q Song","year":"2019","unstructured":"Song Q, et al. A Probiotic Spore-Based Oral Autonomous Nanoparticles Generator for Cancer Therapy. Adv Mater. 2019;31:e1903793.","journal-title":"Adv Mater"},{"key":"4720_CR247","doi-asserted-by":"crossref","unstructured":"Song W, et al. Trapping of lipopolysaccharide to promote immunotherapy against colorectal cancer and attenuate liver metastasis. Adv Mater. 2018;30:e1805007.","DOI":"10.1002\/adma.201805007"},{"key":"4720_CR248","doi-asserted-by":"publisher","first-page":"e04188","DOI":"10.1002\/advs.202504188","volume":"12","author":"Y Niu","year":"2025","unstructured":"Niu Y, et al. Neutrophil-mimicking nanomedicine eliminates tumor intracellular bacteria and enhances chemotherapy on liver metastasis of colorectal cancer. Adv Sci (Weinh). 2025;12:e04188.","journal-title":"Adv Sci (Weinh)"},{"key":"4720_CR249","doi-asserted-by":"crossref","unstructured":"Angsantikul P, et al. Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection. Adv Ther (Weinh). 2018;1(2):1800016.","DOI":"10.1002\/adtp.201800016"},{"key":"4720_CR250","doi-asserted-by":"crossref","unstructured":"Osborne NC, Catania R, Stolnik S, Robinson K. Alpha-linolenic acid-modified liposomes associate with and modulate antibiotic activity against Helicobacter pylori. Microbiol (Reading). 2025;171(5):001562.","DOI":"10.1099\/mic.0.001562"},{"key":"4720_CR251","doi-asserted-by":"publisher","first-page":"e2306281","DOI":"10.1002\/adma.202306281","volume":"35","author":"L Chen","year":"2023","unstructured":"Chen L, et al. Antibacterial Fusobacterium nucleatum-Mimicking Nanomedicine to Selectively Eliminate Tumor-Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer. Adv Mater. 2023;35:e2306281.","journal-title":"Adv Mater"},{"key":"4720_CR252","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.celbio.2025.100092","volume":"1","author":"W Wu","year":"2025","unstructured":"Wu W, et al. Biomimetic Trojan Horse nanoparticles with biotactic behavior toward tumor-associated bacteria for targeted therapy of colorectal cancer. Cell Biomaterials. 2025;1:100092.","journal-title":"Cell Biomaterials"},{"key":"4720_CR253","doi-asserted-by":"publisher","first-page":"137605","DOI":"10.1016\/j.cej.2022.137605","volume":"450","author":"X Yan","year":"2022","unstructured":"Yan X, et al. Construction of size-transformable supramolecular nano-platform against drug-resistant colorectal cancer caused by Fusobacterium nucleatum. Chem Eng J. 2022;450:137605.","journal-title":"Chem Eng J"},{"key":"4720_CR254","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jconrel.2023.11.018","volume":"365","author":"S Xie","year":"2024","unstructured":"Xie S, et al. Size-tunable nanogels for cascaded release of metronidazole and chemotherapeutic agents to combat Fusobacterium nucleatum-infected colorectal cancer. J Control Release. 2024;365:16\u201328.","journal-title":"J Control Release"},{"key":"4720_CR255","doi-asserted-by":"publisher","first-page":"101994","DOI":"10.1016\/j.nantod.2023.101994","volume":"52","author":"Q Chen","year":"2023","unstructured":"Chen Q, et al. Clearing intratumoral bacteria to augment tumor-therapeutic response by engineering antimicrobial dendritic mesoporous silica nanomedicine. Nano Today. 2023;52:101994.","journal-title":"Nano Today"},{"key":"4720_CR256","doi-asserted-by":"publisher","first-page":"101329","DOI":"10.1016\/j.nantod.2021.101329","volume":"41","author":"Z-X Chen","year":"2021","unstructured":"Chen Z-X, et al. Combination gut microbiota modulation and chemotherapy for orthotopic colorectal cancer therapy. Nano Today. 2021;41:101329.","journal-title":"Nano Today"},{"key":"4720_CR257","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41551-021-00807-9","volume":"6","author":"DW Zheng","year":"2022","unstructured":"Zheng DW, et al. Biomaterial-mediated modulation of oral microbiota synergizes with PD-1 blockade in mice with oral squamous cell carcinoma. Nat Biomed Eng. 2022;6:32\u201343.","journal-title":"Nat Biomed Eng"},{"key":"4720_CR258","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s10118-023-2890-x","volume":"41","author":"Y-T Xin","year":"2023","unstructured":"Xin Y-T, et al. Construction of PAMAM-based Nanocomplex Conjugated with Pt(IV)-complex and Lauric Acid Exerting Both Anti-tumor and Antibacterial Effects. Chin J Polym Sci. 2023;41:887\u201396.","journal-title":"Chin J Polym Sci"},{"key":"4720_CR259","doi-asserted-by":"publisher","first-page":"14013","DOI":"10.1002\/anie.202102059","volume":"60","author":"X Zhang","year":"2021","unstructured":"Zhang X, et al. Dual Gate-Controlled Therapeutics for Overcoming Bacterium-Induced Drug Resistance and Potentiating Cancer Immunotherapy. Angew Chem Int Ed Engl. 2021;60:14013\u201321.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4720_CR260","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1021\/acs.nanolett.2c03131","volume":"22","author":"ZY Han","year":"2022","unstructured":"Han ZY, Chen QW, Fu ZJ, Cheng SX, Zhang XZ. Probiotic Spore-Based Oral Drug Delivery System for Enhancing Pancreatic Cancer Chemotherapy by Gut-Pancreas-Axis-Guided Delivery. Nano Lett. 2022;22:8608\u201317.","journal-title":"Nano Lett"},{"key":"4720_CR261","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.1038\/s41467-024-51534-z","volume":"15","author":"ZY Han","year":"2024","unstructured":"Han ZY, et al. Probiotics functionalized with a gallium-polyphenol network modulate the intratumor microbiota and promote anti-tumor immune responses in pancreatic cancer. Nat Commun. 2024;15:7096.","journal-title":"Nat Commun"},{"key":"4720_CR262","first-page":"909","volume":"51","author":"A Jiang","year":"2025","unstructured":"Jiang A, et al. Oral oncolytic magnetotactic bacteria elicit anti-colorectal tumor immunity and reprogram microbiota metabolism. Bioact Mater. 2025;51:909\u201323.","journal-title":"Bioact Mater"},{"key":"4720_CR263","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jconrel.2023.09.028","volume":"363","author":"L Chen","year":"2023","unstructured":"Chen L, et al. Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance. J Control Release. 2023;363:43\u201356.","journal-title":"J Control Release"},{"key":"4720_CR264","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.ijbiomac.2018.01.071","volume":"111","author":"D Wang","year":"2018","unstructured":"Wang D, et al. Inulin based glutathione-responsive delivery system for colon cancer treatment. Int J Biol Macromol. 2018;111:1264\u201372.","journal-title":"Int J Biol Macromol"},{"key":"4720_CR265","doi-asserted-by":"publisher","first-page":"e2310002","DOI":"10.1002\/advs.202310002","volume":"11","author":"H Yao","year":"2024","unstructured":"Yao H, et al. Trojan-Horse Strategy Targeting the Gut-Liver Axis Modulates Gut Microbiome and Reshapes Microenvironment for Orthotopic Hepatocellular Carcinoma Therapy. Adv Sci (Weinh). 2024;11:e2310002.","journal-title":"Adv Sci (Weinh)"},{"key":"4720_CR266","doi-asserted-by":"publisher","first-page":"e1905233","DOI":"10.1002\/smll.201905233","volume":"16","author":"Z Ren","year":"2020","unstructured":"Ren Z, et al. Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis. Small. 2020;16:e1905233.","journal-title":"Small"},{"key":"4720_CR267","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1128\/AEM.00812-15","volume":"81","author":"J Colom","year":"2015","unstructured":"Colom J, et al. Liposome-Encapsulated Bacteriophages for Enhanced Oral Phage Therapy against Salmonella spp. Appl Environ Microbiol. 2015;81:4841\u20139.","journal-title":"Appl Environ Microbiol"},{"key":"4720_CR268","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13568-019-0810-9","volume":"9","author":"AS Abdelsattar","year":"2019","unstructured":"Abdelsattar AS, Abdelrahman F, Dawoud A, Connerton IF, El-Shibiny A. Encapsulation of E. coli phage ZCEC5 in chitosan-alginate beads as a delivery system in phage therapy. AMB Express. 2019;9:87.","journal-title":"AMB Express"},{"key":"4720_CR269","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41551-019-0423-2","volume":"3","author":"DW Zheng","year":"2019","unstructured":"Zheng DW, et al. Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy. Nat Biomed Eng. 2019;3:717\u201328.","journal-title":"Nat Biomed Eng"},{"key":"4720_CR270","doi-asserted-by":"publisher","first-page":"eaba1590","DOI":"10.1126\/sciadv.aba1590","volume":"6","author":"X Dong","year":"2020","unstructured":"Dong X, et al. Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer. Sci Adv. 2020;6:eaba1590.","journal-title":"Sci Adv"},{"key":"4720_CR271","doi-asserted-by":"publisher","first-page":"e2417334","DOI":"10.1002\/adma.202417334","volume":"37","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, et al. A DNA Nanopatch-Bacteriophage System Targeting Streptococcus Gallolyticus for Inflammatory Bowel Disease Treatment and Colorectal Cancer Prevention. Adv Mater. 2025;37:e2417334.","journal-title":"Adv Mater"},{"key":"4720_CR272","doi-asserted-by":"publisher","first-page":"9785","DOI":"10.1038\/s41467-025-65498-1","volume":"16","author":"Y Yang","year":"2025","unstructured":"Yang Y, et al. In situ gut microbiota editing: enhancing therapeutic efficacy for bacterial colitis by compatible oral hydrogel microspheres with phages. Nat Commun. 2025;16:9785.","journal-title":"Nat Commun"},{"key":"4720_CR273","doi-asserted-by":"publisher","first-page":"9594","DOI":"10.1039\/D1TB02134F","volume":"9","author":"H Liu","year":"2021","unstructured":"Liu H, et al. A dendritic polyamidoamine supramolecular system composed of pillar[5]arene and azobenzene for targeting drug-resistant colon cancer. J Mater Chem B. 2021;9:9594\u2013605.","journal-title":"J Mater Chem B"},{"key":"4720_CR274","doi-asserted-by":"publisher","first-page":"101544","DOI":"10.1016\/j.apmt.2022.101544","volume":"28","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. Intestinal delivery of ROS-scavenging carbonized polymer dots for full-course treatment of acute and chronic radiation enteritis. Appl Mater Today. 2022;28:101544.","journal-title":"Appl Mater Today"},{"key":"4720_CR275","doi-asserted-by":"publisher","first-page":"eadd2789","DOI":"10.1126\/sciadv.add2789","volume":"8","author":"J Chen","year":"2022","unstructured":"Chen J, et al. Nitroreductase-instructed supramolecular assemblies for microbiome regulation to enhance colorectal cancer treatments. Sci Adv. 2022;8:eadd2789.","journal-title":"Sci Adv"},{"key":"4720_CR276","doi-asserted-by":"publisher","first-page":"e2301309","DOI":"10.1002\/smtd.202301309","volume":"8","author":"X Yan","year":"2024","unstructured":"Yan X, et al. Remotely Controllable Supramolecular Nanomedicine for Drug-Resistant Colorectal Cancer Therapy Caused by Fusobacterium nucleatum. Small Methods. 2024;8:e2301309.","journal-title":"Small Methods"},{"key":"4720_CR277","doi-asserted-by":"crossref","unstructured":"Yao WQ et al. Harnessing the Engineered Probiotic-Nanosystem to Remodulate Tumor Extracellular Matrix and Regulate Tumor-Colonizing Bacteria for Improving Pancreatic Cancer Chemo-Immunotherapy. Small 21, e2406837 (2025).","DOI":"10.1002\/smll.202406837"},{"key":"4720_CR278","doi-asserted-by":"publisher","first-page":"7335","DOI":"10.1021\/acsnano.2c11305","volume":"17","author":"C Gao","year":"2023","unstructured":"Gao C, et al. Synergistic Target of Intratumoral Microbiome and Tumor by Metronidazole-Fluorouridine Nanoparticles. ACS Nano. 2023;17:7335\u201351.","journal-title":"ACS Nano"},{"key":"4720_CR279","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jconrel.2024.05.002","volume":"370","author":"S Ma","year":"2024","unstructured":"Ma S, et al. Orally available dextran-aspirin nanomedicine modulates gut inflammation and microbiota homeostasis for primary colorectal cancer therapy. J Control Release. 2024;370:528\u201342.","journal-title":"J Control Release"},{"key":"4720_CR280","doi-asserted-by":"publisher","first-page":"14043","DOI":"10.1021\/acsnano.2c03911","volume":"16","author":"X Xia","year":"2022","unstructured":"Xia X, et al. In Situ Upregulating Heat Shock Protein 70 via Gastric Nano-Heaters for the Interference of Helicobacter pylori Infection. ACS Nano. 2022;16:14043\u201354.","journal-title":"ACS Nano"},{"key":"4720_CR281","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41467-024-45156-8","volume":"15","author":"T Liu","year":"2024","unstructured":"Liu T, et al. A nanoparticle-based sonodynamic therapy reduces Helicobacter pylori infection in mouse without disrupting gut microbiota. Nat Commun. 2024;15:844.","journal-title":"Nat Commun"},{"key":"4720_CR282","doi-asserted-by":"publisher","first-page":"e2105523","DOI":"10.1002\/advs.202105523","volume":"9","author":"F Kong","year":"2022","unstructured":"Kong F, et al. Abundance and Metabolism Disruptions of Intratumoral Microbiota by Chemical and Physical Actions Unfreeze Tumor Treatment Resistance. Adv Sci (Weinh). 2022;9:e2105523.","journal-title":"Adv Sci (Weinh)"},{"key":"4720_CR283","doi-asserted-by":"publisher","first-page":"11466","DOI":"10.1021\/acsnano.3c01308","volume":"17","author":"X Qu","year":"2023","unstructured":"Qu X, et al. Modulation of Intratumoral Fusobacterium nucleatum to Enhance Sonodynamic Therapy for Colorectal Cancer with Reduced Phototoxic Skin Injury. ACS Nano. 2023;17:11466\u201380.","journal-title":"ACS Nano"},{"key":"4720_CR284","doi-asserted-by":"publisher","first-page":"e2206765","DOI":"10.1002\/adma.202206765","volume":"34","author":"X Kang","year":"2022","unstructured":"Kang X, et al. Dual-Cascade Responsive Nanoparticles Enhance Pancreatic Cancer Therapy by Eliminating Tumor-Resident Intracellular Bacteria. Adv Mater. 2022;34:e2206765.","journal-title":"Adv Mater"},{"key":"4720_CR285","doi-asserted-by":"publisher","first-page":"102019","DOI":"10.1016\/j.nano.2019.102019","volume":"20","author":"X Zhi","year":"2019","unstructured":"Zhi X, et al. Oral pH sensitive GNS@ab nanoprobes for targeted therapy of Helicobacter pylori without disturbance gut microbiome. Nanomedicine. 2019;20:102019.","journal-title":"Nanomedicine"},{"key":"4720_CR286","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.actbio.2023.11.019","volume":"173","author":"X Li","year":"2024","unstructured":"Li X, et al. Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer. Acta Biomater. 2024;173:432\u201341.","journal-title":"Acta Biomater"},{"key":"4720_CR287","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jconrel.2023.05.034","volume":"359","author":"Y Xin","year":"2023","unstructured":"Xin Y, et al. In situ-activated photothermal nanoplatform for on-demand NO gas delivery and enhanced colorectal cancer treatment. J Control Release. 2023;359:69\u201384.","journal-title":"J Control Release"},{"key":"4720_CR288","doi-asserted-by":"publisher","first-page":"11063","DOI":"10.1021\/acsami.0c00310","volume":"12","author":"S Zhu","year":"2020","unstructured":"Zhu S, Wang X, Li S, Liu L, Li L. Near-Infrared-Light-Assisted in Situ Reduction of Antimicrobial Peptide-Protected Gold Nanoclusters for Stepwise Killing of Bacteria and Cancer Cells. ACS Appl Mater Interfaces. 2020;12:11063\u201371.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4720_CR289","doi-asserted-by":"publisher","first-page":"137340","DOI":"10.1016\/j.cej.2022.137340","volume":"446","author":"L Shi","year":"2022","unstructured":"Shi L, et al. Regulation of gut microbiome with redox responsible bacterial cellulose hydrogel for precision chemo-radiotherapy of intestinal cancer. Chem Eng J. 2022;446:137340.","journal-title":"Chem Eng J"},{"key":"4720_CR290","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s41587-023-01957-8","volume":"42","author":"M Wang","year":"2024","unstructured":"Wang M, et al. Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses. Nat Biotechnol. 2024;42:1263\u201374.","journal-title":"Nat Biotechnol"},{"key":"4720_CR291","doi-asserted-by":"publisher","first-page":"11250","DOI":"10.1039\/D0NR07981B","volume":"13","author":"L Deng","year":"2021","unstructured":"Deng L, et al. Se@Albumin nanoparticles ameliorate intestinal mucositis caused by cisplatin via gut microbiota-targeted regulation. Nanoscale. 2021;13:11250\u201361.","journal-title":"Nanoscale"},{"key":"4720_CR292","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41392-023-01491-8","volume":"8","author":"X Wang","year":"2023","unstructured":"Wang X, et al. Destroying pathogen-tumor symbionts synergizing with catalytic therapy of colorectal cancer by biomimetic protein-supported single-atom nanozyme. Signal Transduct Target Ther. 2023;8:277.","journal-title":"Signal Transduct Target Ther"},{"key":"4720_CR293","doi-asserted-by":"publisher","first-page":"122530","DOI":"10.1016\/j.biomaterials.2024.122530","volume":"307","author":"B Li","year":"2024","unstructured":"Li B, et al. Magnetic natural lipid nanoparticles for oral treatment of colorectal cancer through potentiated antitumor immunity and microbiota metabolite regulation. Biomaterials. 2024;307:122530.","journal-title":"Biomaterials"},{"key":"4720_CR294","doi-asserted-by":"publisher","first-page":"e2004529","DOI":"10.1002\/adma.202004529","volume":"32","author":"DW Zheng","year":"2020","unstructured":"Zheng DW, et al. Prebiotics-Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer. Adv Mater. 2020;32:e2004529.","journal-title":"Adv Mater"},{"key":"4720_CR295","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41467-022-28744-4","volume":"13","author":"D Zhang","year":"2022","unstructured":"Zhang D, et al. Microalgae-based oral microcarriers for gut microbiota homeostasis and intestinal protection in cancer radiotherapy. Nat Commun. 2022;13:1413.","journal-title":"Nat Commun"},{"key":"4720_CR296","doi-asserted-by":"crossref","unstructured":"Liu X, Wang L, Jing N, Jiang G, Liu Z. Biostimulating gut microbiome with bilberry anthocyanin combo to enhance anti-PD-L1 efficiency against murine colon cancer. Microorganisms. 2020;8(2):175.","DOI":"10.3390\/microorganisms8020175"},{"key":"4720_CR297","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1038\/s41467-023-40439-y","volume":"14","author":"T Lang","year":"2023","unstructured":"Lang T, et al. Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy. Nat Commun. 2023;14:4746.","journal-title":"Nat Commun"},{"key":"4720_CR298","doi-asserted-by":"crossref","unstructured":"Zhu R, et al. Inulin-based nanoparticle modulates gut microbiota and immune microenvironment for improving colorectal cancer therapy. Adv Funct Mater. 2024;34:2407685.","DOI":"10.1002\/adfm.202407685"},{"key":"4720_CR299","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.chom.2015.12.016","volume":"19","author":"N Zmora","year":"2016","unstructured":"Zmora N, Zeevi D, Korem T, Segal E, Elinav E. Taking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease. Cell Host Microbe. 2016;19:12\u201320.","journal-title":"Cell Host Microbe"},{"key":"4720_CR300","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3945\/ajcn.117.156380","volume":"106","author":"JL Kaczmarek","year":"2017","unstructured":"Kaczmarek JL, Musaad SM, Holscher HD. Time of day and eating behaviors are associated with the composition and function of the human gastrointestinal microbiota. Am J Clin Nutr. 2017;106:1220\u201331.","journal-title":"Am J Clin Nutr"},{"key":"4720_CR301","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1136\/gutjnl-2022-328034","volume":"72","author":"J Fu","year":"2023","unstructured":"Fu J, et al. Ageing trajectory of the gut microbiota is associated with metabolic diseases in a chronological age-dependent manner. Gut. 2023;72:1431\u20133.","journal-title":"Gut"},{"key":"4720_CR302","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s00248-021-01786-9","volume":"83","author":"CA Febinia","year":"2022","unstructured":"Febinia CA, et al. Distinctive Microbiome Type Distribution in a Young Adult Balinese Cohort May Reflect Environmental Changes Associated with Modernization. Microb Ecol. 2022;83:798\u2013810.","journal-title":"Microb Ecol"},{"key":"4720_CR303","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s40168-024-01927-5","volume":"12","author":"S Levi Mortera","year":"2024","unstructured":"Levi Mortera S, et al. Metaproteomics reveals diet-induced changes in gut microbiome function according to Crohn\u2019s disease location. Microbiome. 2024;12:217.","journal-title":"Microbiome"},{"key":"4720_CR304","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ccell.2024.08.019","volume":"42","author":"X Wang","year":"2024","unstructured":"Wang X, et al. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer. Cancer Cell. 2024;42:1729\u2013e17461728.","journal-title":"Cancer Cell"},{"key":"4720_CR305","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00535-023-02069-5","volume":"59","author":"S Abe","year":"2024","unstructured":"Abe S, et al. Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma. J Gastroenterol. 2024;59:250\u201362.","journal-title":"J Gastroenterol"},{"key":"4720_CR306","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"K Hezaveh","year":"2022","unstructured":"Hezaveh K, et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 2022;55:324\u2013e340328.","journal-title":"Immunity"},{"key":"4720_CR307","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4161\/gmic.21737","volume":"3","author":"M Olier","year":"2012","unstructured":"Olier M, et al. Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes. 2012;3:501\u20139.","journal-title":"Gut Microbes"},{"key":"4720_CR308","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1126\/science.aad3503","volume":"352","author":"G Falony","year":"2016","unstructured":"Falony G, et al. Population-level analysis of gut microbiome variation. Science. 2016;352:560\u20134.","journal-title":"Science"},{"key":"4720_CR309","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41579-024-01107-0","volume":"23","author":"R Joos","year":"2025","unstructured":"Joos R, et al. Examining the healthy human microbiome concept. Nat Rev Microbiol. 2025;23:192\u2013205.","journal-title":"Nat Rev Microbiol"},{"key":"4720_CR310","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.mayocp.2017.10.004","volume":"92","author":"PC Kashyap","year":"2017","unstructured":"Kashyap PC, Chia N, Nelson H, Segal E, Elinav E. Microbiome at the Frontier of Personalized Medicine. Mayo Clin Proc. 2017;92:1855\u201364.","journal-title":"Mayo Clin Proc"},{"key":"4720_CR311","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.1016\/j.cell.2024.09.019","volume":"187","author":"G Wu","year":"2024","unstructured":"Wu G, et al. A core microbiome signature as an indicator of health. Cell. 2024;187:6550\u2013e65656511.","journal-title":"Cell"},{"key":"4720_CR312","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41579-019-0242-1","volume":"17","author":"AE Douglas","year":"2019","unstructured":"Douglas AE. Simple animal models for microbiome research. Nat Rev Microbiol. 2019;17:764\u201375.","journal-title":"Nat Rev Microbiol"},{"key":"4720_CR313","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.coph.2019.03.016","volume":"49","author":"T Uzbay","year":"2019","unstructured":"Uzbay T. Germ-free animal experiments in the gut microbiota studies. Curr Opin Pharmacol. 2019;49:6\u201310.","journal-title":"Curr Opin Pharmacol"},{"key":"4720_CR314","doi-asserted-by":"publisher","first-page":"757","DOI":"10.4014\/jmb.2311.11024","volume":"34","author":"HS Song","year":"2024","unstructured":"Song HS, Kim YB, Kim JY, Roh SW, Whon TW. Advances in Culturomics Research on the Human Gut Microbiome: Optimizing Medium Composition and Culture Techniques for Enhanced Microbial Discovery. J Microbiol Biotechnol. 2024;34:757\u201364.","journal-title":"J Microbiol Biotechnol"},{"key":"4720_CR315","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/cac2.12200","volume":"41","author":"MH Lee","year":"2021","unstructured":"Lee MH. Harness the functions of gut microbiome in tumorigenesis for cancer treatment. Cancer Commun (Lond). 2021;41:937\u201367.","journal-title":"Cancer Commun (Lond)"},{"key":"4720_CR316","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s41591-023-02324-5","volume":"29","author":"J Roelands","year":"2023","unstructured":"Roelands J, et al. An integrated tumor, immune and microbiome atlas of colon cancer. Nat Med. 2023;29:1273\u201386.","journal-title":"Nat Med"},{"key":"4720_CR317","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ccell.2022.11.013","volume":"41","author":"H Teng","year":"2023","unstructured":"Teng H, et al. Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer. Cancer Cell. 2023;41:124\u2013e138126.","journal-title":"Cancer Cell"},{"key":"4720_CR318","doi-asserted-by":"publisher","first-page":"2297860","DOI":"10.1080\/19490976.2023.2297860","volume":"16","author":"A Chetty","year":"2024","unstructured":"Chetty A, Blekhman R. Multi-omic approaches for host-microbiome data integration. Gut Microbes. 2024;16:2297860.","journal-title":"Gut Microbes"},{"key":"4720_CR319","doi-asserted-by":"publisher","first-page":"2569739","DOI":"10.1080\/19490976.2025.2569739","volume":"17","author":"HA Tegegne","year":"2025","unstructured":"Tegegne HA, Savidge TC. Gut microbiome metagenomics in clinical practice: bridging the gap between research and precision medicine. Gut Microbes. 2025;17:2569739.","journal-title":"Gut Microbes"},{"key":"4720_CR320","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41571-025-01049-3","volume":"22","author":"JB Xavier","year":"2025","unstructured":"Xavier JB. Ecological management of the microbiota in patients with cancer. Nat Rev Clin Oncol. 2025;22:627\u201339.","journal-title":"Nat Rev Clin Oncol"},{"key":"4720_CR321","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12989-016-0149-1","volume":"13","author":"S van den Brule","year":"2016","unstructured":"van den Brule S, et al. Dietary silver nanoparticles can disturb the gut microbiota in mice. Part Fibre Toxicol. 2016;13:38.","journal-title":"Part Fibre Toxicol"},{"key":"4720_CR322","doi-asserted-by":"publisher","first-page":"13786","DOI":"10.1038\/s41598-020-69745-x","volume":"10","author":"A Chaplin","year":"2020","unstructured":"Chaplin A, et al. Systemically-delivered biodegradable PLGA alters gut microbiota and induces transcriptomic reprogramming in the liver in an obesity mouse model. Sci Rep. 2020;10:13786.","journal-title":"Sci Rep"},{"key":"4720_CR323","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","volume":"19","author":"S Sindhwani","year":"2020","unstructured":"Sindhwani S, et al. The entry of nanoparticles into solid tumours. Nat Mater. 2020;19:566\u201375.","journal-title":"Nat Mater"},{"key":"4720_CR324","unstructured":"U.S. Food and Drug Administration. Drug products, including biological products, that contain nanomaterials: guidance for industry. Silver Spring, MD: U.S. Food and Drug Administration; 2022."},{"key":"4720_CR325","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"Y Barenholz","year":"2012","unstructured":"Barenholz Y. Doxil\u00ae--the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160:117\u201334.","journal-title":"J Control Release"},{"key":"4720_CR326","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","volume":"14","author":"A Akinc","year":"2019","unstructured":"Akinc A, et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat Nanotechnol. 2019;14:1084\u20137.","journal-title":"Nat Nanotechnol"},{"key":"4720_CR327","doi-asserted-by":"publisher","first-page":"128ra139","DOI":"10.1126\/scitranslmed.3003651","volume":"4","author":"J Hrkach","year":"2012","unstructured":"Hrkach J, et al. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile. Sci Transl Med. 2012;4:128ra139.","journal-title":"Sci Transl Med"},{"key":"4720_CR328","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","volume":"9","author":"D Rosenblum","year":"2018","unstructured":"Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9:1410.","journal-title":"Nat Commun"},{"key":"4720_CR329","doi-asserted-by":"publisher","first-page":"17955","DOI":"10.1021\/acsami.6b05840","volume":"8","author":"HJ Im","year":"2016","unstructured":"Im HJ, et al. Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease. ACS Appl Mater Interfaces. 2016;8:17955\u201363.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4720_CR330","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.2147\/IJN.S36111","volume":"7","author":"E Fr\u00f6hlich","year":"2012","unstructured":"Fr\u00f6hlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed. 2012;7:5577\u201391.","journal-title":"Int J Nanomed"},{"key":"4720_CR331","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.addr.2011.06.017","volume":"63","author":"J Szebeni","year":"2011","unstructured":"Szebeni J, Muggia F, Gabizon A, Barenholz Y. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention. Adv Drug Deliv Rev. 2011;63:1020\u201330.","journal-title":"Adv Drug Deliv Rev"},{"key":"4720_CR332","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3389\/fphar.2018.00790","volume":"9","author":"S Hua","year":"2018","unstructured":"Hua S, de Matos MBC, Metselaar JM, Storm G. Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization. Front Pharmacol. 2018;9:790.","journal-title":"Front Pharmacol"},{"key":"4720_CR333","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1002\/imt2.213","volume":"3","author":"Y Wei","year":"2024","unstructured":"Wei Y, et al. The challenge and opportunity of gut microbiota-targeted nanomedicine for colorectal cancer therapy. Imeta. 2024;3:e213.","journal-title":"Imeta"},{"key":"4720_CR334","doi-asserted-by":"crossref","unstructured":"Zhu R, et al. Inulin-based nanoparticle modulates gut microbiota and immune microenvironment for improving colorectal cancer therapy. Adv Funct Mater. 2024;34:2407685.","DOI":"10.1002\/adfm.202407685"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04720-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04720-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04720-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:04:18Z","timestamp":1790172258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04720-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":334,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4720"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04720-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"895"}}